An	O
activation-responsive	O
element	O
in	O
single	O
C	B-DNA
motif-1/lymphotactin	I-DNA
promoter	I-DNA
is	O
a	O
site	O
of	O
constitutive	O
and	O
inducible	O
DNA-protein	O
interactions	O
involving	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cell	I-protein
.	O

Single	B-protein
C	I-protein
motif-1	I-protein
(	I-protein
SCM-1	I-protein
)	I-protein
/lymphotactin	I-protein
is	O
a	O
C-type	B-protein
chemokine	I-protein
whose	O
expression	O
is	O
activation	O
dependent	O
,	O
cyclosporin	O
A	O
sensitive	O
and	O
restricted	O
to	O
CD8+	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
double-negative	B-cell_type
thymocytes	I-cell_type
,	O
gammadelta-type	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
and	O
NK	B-cell_type
cells	I-cell_type
.	O

In	O
humans	O
,	O
there	O
are	O
two	O
highly	O
homologous	B-DNA
genes	I-DNA
encoding	O
SCM-1alpha	B-protein
and	O
SCM-1beta	B-protein
.	O

Here	O
we	O
examined	O
the	O
regulatory	O
mechanism	O
of	O
the	O
SCM-1	B-DNA
genes	I-DNA
.	O

The	O
luciferase	B-DNA
reporter	I-DNA
gene	I-DNA
under	O
the	O
control	O
of	O
the	O
5	B-DNA
'	I-DNA
flanking	I-DNA
region	I-DNA
of	O
0.7	O
kb	O
was	O
strongly	O
induced	O
upon	O
activation	O
with	O
anti-CD3	B-protein
or	O
PHA	B-protein
plus	O
PMA	O
only	O
in	O
SCM-1-producer	B-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
through	O
a	O
cyclosporin	O
A-sensitive	O
mechanism	O
.	O

An	O
element	O
termed	O
E1	B-DNA
located	O
at	O
-108	B-DNA
to	I-DNA
-95	I-DNA
nt	I-DNA
relative	O
to	O
the	O
major	O
transcription	O
start	O
site	O
was	O
found	O
to	O
be	O
critical	O
for	O
the	O
promoter	O
activity	O
.	O

In	O
electrophoretic	O
mobility	O
shift	O
assays	O
using	O
the	O
E1	B-DNA
oligonucleotide	O
as	O
probe	O
,	O
nuclear	O
extracts	O
from	O
unstimulated	O
T	O
and	O
B	B-cell_line
cell	I-cell_line
lines	I-cell_line
formed	O
a	O
constitutive	B-protein
complex	I-protein
termed	O
complex	B-protein
I	I-protein
,	O
while	O
nuclear	O
extracts	O
from	O
stimulated	O
SCM-1-producer	B-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
formed	O
a	O
higher	B-protein
mobility	I-protein
complex	I-protein
termed	O
complex	B-protein
II	I-protein
with	O
a	O
concomitant	O
decrease	O
in	O
complex	B-protein
I	I-protein
.	O

The	O
shift	O
from	O
complex	B-protein
I	I-protein
to	O
complex	B-protein
II	I-protein
seen	O
only	O
in	O
SCM-1-producer	B-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
upon	O
activation	O
was	O
completely	O
suppressed	O
by	O
cyclosporin	O
A	O
.	O

Both	O
complexes	O
were	O
critically	O
dependent	O
on	O
the	O
NF-AT	B-DNA
core	I-DNA
sequence	I-DNA
TTTCC	O
in	O
the	O
E1	B-DNA
element	I-DNA
and	O
were	O
partially	O
supershifted	O
by	O
anti-NF-ATp	B-protein
.	O

One-hybrid	O
assays	O
in	O
yeast	B-protein
isolated	I-protein
NF-ATp	I-protein
as	O
an	O
E1	B-protein
binding	I-protein
protein	I-protein
,	O
and	O
transfection	O
of	O
NF-ATp	B-protein
into	O
T	B-cell_line
and	I-cell_line
B	I-cell_line
cell	I-cell_line
lines	I-cell_line
strongly	O
enhanced	O
the	O
activation-dependent	B-protein
SCM-1	I-protein
promoter	O
activity	O
.	O

Collectively	O
,	O
a	O
unique	O
mechanism	O
involving	O
NF-ATp	B-protein
appears	O
to	O
regulate	O
the	O
cell	O
type-specific	O
and	O
activation-dependent	O
expression	O
of	O
the	O
SCM-1	B-DNA
genes	I-DNA
.	O

'_9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MICFOVUG	NULL
Wim	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
CSa	NULL
,	NULL
s	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
|	NULL
QUIpEL	NULL
MULTIPLEX	NULL
I	NULL
ill	NULL
``	NULL
``	NULL
A	NULL
SE	NULL
ANTS	NULL
ty	NULL
ay	NULL
Sa	NULL
meJournal	NULL
of	NULL
An	NULL
Activation-Responsive	NULL
Element	NULL
in	NULL
Single	NULL
C	NULL
Immunolo	NULL
gy	NULL
C	NULL
Motif-1/Lymphotactin	NULL
Promoter	NULL
Is	NULL
a	NULL
Site	NULL
of	NULL
Constitutive	NULL
and	NULL
Inducible	NULL
DNA-Protein	NULL
Interactions	NULL
Involving	NULL
Nuclear	NULL
Factor	NULL
of	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Acti	NULL
T	NULL
I	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019.	NULL
ctivated	NULL
T	NULL
Ce	NULL
Tetsuya	NULL
Yoshida	NULL
,	NULL
Izumi	NULL
Ishikawa	NULL
,	NULL
Yuichi	NULL
Ono	NULL
,	NULL
Toshio	NULL
Imai	NULL
,	NULL
Ryuji	NULL
Suzuki	NULL
and	NULL
Osamu	NULL
Yoshie	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
163:3295-3303	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/6/3295	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
37	NULL
articles	NULL
,	NULL
21	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/6/3295	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
An	NULL
Activation-Responsive	NULL
Element	NULL
in	NULL
Single	NULL
C	NULL
Motif-1/	NULL
Lymphotactin	NULL
Promoter	NULL
Is	NULL
a	NULL
Site	NULL
of	NULL
Constitutive	NULL
and	NULL
Inducible	NULL
DNA	NULL
Interactions	NULL
Involving	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cell	NULL
'	NULL
Tetsuya	NULL
Yoshida	NULL
,	NULL
*	NULL
Izumi	NULL
Ishikawa	NULL
,	NULL
*	NULL
Yuichi	NULL
Ono	NULL
,	NULL
*	NULL
Toshio	NULL
Imai	NULL
,	NULL
*	NULL
``	NULL
Ryuji	NULL
Suzuki	NULL
,	NULL
*	NULL
and	NULL
Osamu	NULL
Yoshie	NULL
``	NULL
**	NULL
Single	NULL
C	NULL
motif-1	NULL
(	NULL
SCM-1	NULL
)	NULL
/lymphotactin	NULL
is	NULL
a	NULL
C-type	NULL
chemokine	NULL
whose	NULL
expression	NULL
is	NULL
activation	NULL
dependent	NULL
,	NULL
cyclosporin	NULL
A	NULL
sensitive	NULL
and	NULL
restricted	NULL
to	NULL
CD8*	NULL
T	NULL
cells	NULL
,	NULL
double-negative	NULL
thymocytes	NULL
,	NULL
y5-type	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
there	NULL
are	NULL
two	NULL
highly	NULL
homologous	NULL
genes	NULL
encoding	NULL
SCM-la	NULL
&	NULL
and	NULL
SCM-1§	NULL
.	NULL

Here	NULL
we	NULL
examined	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
0.7	NULL
kb	NULL
was	NULL
strongly	NULL
induced	NULL
upon	NULL
activation	NULL
with	NULL
anti-CD3	NULL
or	NULL
PHA	NULL
plus	NULL
PMA	NULL
only	NULL
in	NULL
SCM-1-producer	NULL
T	NULL
cell	NULL
lines	NULL
through	NULL
a	NULL
cyclosporin	NULL
A-sensitive	NULL
mechanism	NULL
.	NULL

An	NULL
element	NULL
termed	NULL
E1	NULL
located	NULL
at	NULL
-108	NULL
to	NULL
-95	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
was	NULL
found	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
the	NULL
E1	NULL
oligonucleotide	NULL
as	NULL
probe	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
formed	NULL
a	NULL
constitutive	NULL
complex	NULL
termed	NULL
complex	NULL
I	NULL
,	NULL
while	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
SCM-1-producer	NULL
T	NULL
cell	NULL
lines	NULL
formed	NULL
a	NULL
higher	NULL
mobility	NULL
complex	NULL
termed	NULL
complex	NULL
II	NULL
with	NULL
a	NULL
concomitant	NULL
decrease	NULL
in	NULL
complex	NULL
I	NULL
.	NULL

The	NULL
shift	NULL
from	NULL
complex	NULL
I	NULL
to	NULL
complex	NULL
II	NULL
seen	NULL
only	NULL
in	NULL
SCM-1-producer	NULL
T	NULL
cell	NULL
lines	NULL
upon	NULL
activation	NULL
was	NULL
completely	NULL
suppressed	NULL
by	NULL
cyclosporin	NULL
A	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
critically	NULL
dependent	NULL
on	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
TTTCC	NULL
in	NULL
the	NULL
E1	NULL
element	NULL
and	NULL
were	NULL
partially	NULL
supershifted	NULL
by	NULL
anti-NF-ATp	NULL
.	NULL

One-hybrid	NULL
assays	NULL
in	NULL
yeast	NULL
isolated	NULL
NF-ATp	NULL
as	NULL
an	NULL
E1	NULL
binding	NULL
protein	NULL
,	NULL
and	NULL
transfection	NULL
of	NULL
NF-ATp	NULL
into	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
strongly	NULL
enhanced	NULL
the	NULL
activation-dependent	NULL
SCM-1	NULL
promoter	NULL
activity	NULL
.	NULL

Collectively	NULL
,	NULL
a	NULL
unique	NULL
mechanism	NULL
involving	NULL
NF-ATp	NULL
appears	NULL
to	NULL
regulate	NULL
the	NULL
cell	NULL
type-specific	NULL
and	NULL
activation-dependent	NULL
expression	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
163	NULL
:	NULL
3295-3303.	NULL
ingle	NULL
C	NULL
motif-1	NULL
(	NULL
SCM-1	NULL
)	NULL
*/lymphotactin/activation-in-	NULL
duced	NULL
,	NULL
T	NULL
cell-derived	NULL
,	NULL
and	NULL
chemokine-related	NULL
molecule	NULL
(	NULL
ATAC	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
cytokine	NULL
produced	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

It	NULL
has	NULL
a	NULL
significant	NULL
structural	NULL
homology	NULL
to	NULL
chemokines	NULL
,	NULL
especially	NULL
to	NULL
the	NULL
CC	NULL
subfamily	NULL
,	NULL
but	NULL
lacks	NULL
the	NULL
first	NULL
and	NULL
third	NULL
of	NULL
the	NULL
four	NULL
canonical	NULL
cysteine	NULL
residues	NULL
conserved	NULL
in	NULL
other	NULL
chemokines	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
considered	NULL
to	NULL
represent	NULL
the	NULL
C	NULL
subfamily	NULL
of	NULL
chemokine	NULL
.	NULL

The	NULL
pathophysiologic	NULL
functions	NULL
of	NULL
SCM-1	NULL
are	NULL
still	NULL
mostly	NULL
unknown	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
chemotactic	NULL
for	NULL
lymphocytes	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
4-6	NULL
)	NULL
.	NULL

It	NULL
was	NULL
found	NULL
to	NULL
be	NULL
selectively	NULL
expressed	NULL
by	NULL
activated	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
double-negative	NULL
«	NULL
B-type	NULL
thymocytes	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
epidermal	NULL
dendritic	NULL
y8-type	NULL
T	NULL
cells	NULL
and	NULL
intestinal	NULL
intraepithelial	NULL
y8-type	NULL
T	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
produce	NULL
copious	NULL
amounts	NULL
of	NULL
this	NULL
cytokine	NULL
upon	NULL
activation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

IL-2-activated	NULL
murine	NULL
NK	NULL
cells	NULL
and	NULL
human	NULL
NK	NULL
clones	NULL
were	NULL
also	NULL
shown	NULL
to	NULL
express	NULL
its	NULL
mRNA	NULL
(	NULL
6	NULL
)	NULL
.	NULL

*Shionogi	NULL
Institute	NULL
for	NULL
Medical	NULL
Science	NULL
,	NULL
Mishima	NULL
,	NULL
Settsu-shi	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
*De-partment	NULL
of	NULL
Bacteriology	NULL
,	NULL
Kinki	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Ohno-Higashi	NULL
,	NULL
Osa-ka-Sayama	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
Received	NULL
for	NULL
publication	NULL
October	NULL
13	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
July	NULL
7	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
The	NULL
nucleic	NULL
acid	NULL
sequences	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
have	NULL
been	NULL
deposited	NULL
in	NULL
the	NULL
DDBJ/	NULL
EMBL/GenBank	NULL
databases	NULL
with	NULL
accession	NULL
numbers	NULL
D63790	NULL
and	NULL
D63789	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Osamu	NULL
Yoshie	NULL
,	NULL
Department	NULL
of	NULL
Bacteriology	NULL
,	NULL
Kinki	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
377-2	NULL
Ohno-Higashi	NULL
,	NULL
Osaka-Sayama	NULL
,	NULL
Osaka	NULL
589-8511	NULL
,	NULL
Japan	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
o.yoshie	NULL
@	NULL
med.kindai.ac.jp	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
SCM-1	NULL
,	NULL
single	NULL
C	NULL
motif-1	NULL
;	NULL
ATAC	NULL
,	NULL
activation-induced	NULL
,	NULL
T	NULL
cell-derived	NULL
and	NULL
chemokine-related	NULL
molecule	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
XCR	NULL
1	NULL
,	NULL
XC	NULL
chemokine	NULL
receptor	NULL
1	NULL
;	NULL
E1	NULL
,	NULL
element	NULL
1	NULL
;	NULL
ARE	NULL
,	NULL
activation-responsive	NULL
element	NULL
;	NULL
B-gal	NULL
,	NULL
B-galactosidase	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
Thus	NULL
,	NULL
SCM-1/lymphotactin/ATAC	NULL
is	NULL
a	NULL
unique	NULL
cytokine	NULL
whose	NULL
expression	NULL
is	NULL
highly	NULL
selective	NULL
for	NULL
certain	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
study	NULL
we	NULL
isolated	NULL
genomic	NULL
clones	NULL
hybridizing	NULL
with	NULL
the	NULL
SCM-1	NULL
cDNA	NULL
.	NULL

There	NULL
are	NULL
two	NULL
highly	NULL
homologous	NULL
SCM-1	NULL
genes	NULL
,	NULL
termed	NULL
and	NULL
SCYC2	NULL
,	NULL
in	NULL
the	NULL
human	NULL
genome	NULL
(	NULL
8	NULL
)	NULL
.	NULL

These	NULL
two	NULL
genes	NULL
are	NULL
closely	NULL
mapped	NULL
to	NULL
human	NULL
chromosome	NULL
19423	NULL
,	NULL
similarly	NULL
inducible	NULL
in	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
and	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
upon	NULL
activation	NULL
,	NULL
and	NULL
encode	NULL
SCM-1a	NULL
«	NULL
and	NULL
SCM-1	NULL
$	NULL
with	NULL
only	NULL
two	NULL
amino	NULL
acid	NULL
differences	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
identified	NULL
a	NULL
specific	NULL
functional	NULL
receptor	NULL
for	NULL
SCM-1a	NULL
and	NULL
SCM-1	NULL
,	NULL
now	NULL
termed	NULL
XCR1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
seven-transmembrane	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
selectively	NULL
expressed	NULL
in	NULL
tissues	NULL
such	NULL
as	NULL
placenta	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
thymus	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
SCM-1	NULL
gene	NULL
expression	NULL
in	NULL
particular	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Because	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
suppress	NULL
the	NULL
induction	NULL
of	NULL
this	NULL
protein	NULL
in	NULL
activated	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
,	NULL
the	NULL
NF-AT	NULL
family	NULL
transcription	NULL
factors	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
its	NULL
expression	NULL
(	NULL
10	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
an	NULL
NF-AT-like	NULL
cis-acting	NULL
element	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
termed	NULL
E1	NULL
is	NULL
essential	NULL
and	NULL
sufficient	NULL
for	NULL
activation-dependent	NULL
,	NULL
cell	NULL
type-specific	NULL
,	NULL
and	NULL
CsA-sensitive	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
further	NULL
demonstrated	NULL
that	NULL
E1	NULL
is	NULL
a	NULL
site	NULL
of	NULL
constitutive	NULL
and	NULL
activation-inducible	NULL
DNA-protein	NULL
interactions	NULL
involving	NULL
NF-AT	NULL
family	NULL
proteins	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
Human	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
Jurkat	NULL
,	NULL
PEER	NULL
,	NULL
and	NULL
HPB-ALL	NULL
,	NULL
and	NULL
a	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
BALL-1	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
)	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
and	NULL
HeLa-S3	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
,	NULL
and	NULL
kanamycin	NULL
(	NULL
30	NULL
ug/ml	NULL
)	NULL
.	NULL

PBMC	NULL
were	NULL
isolated	NULL
from	NULL
heparinized	NULL
venous	NULL
blood	NULL
from	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3296	NULL
REGULATION	NULL
OF	NULL
SCM-1/LYMPHOTACTIN	NULL
BY	NULL
NF-AT	NULL
OCT-1	NULL
MYB	NULL
SCM-1	NULL
a	NULL
-669	NULL
AAGCTTCTATAAATGTGTATGTTAAGTTGTAATAAAGCAAACACATGCATGT-AGACATGCTTAAACAGTTATTTAATTGTTTCTTGGGTACCTGGG	NULL
SCM-1	NULL
B	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

Avus	NULL
y	NULL
.e	NULL
.	NULL

ee	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
eee	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
ene	NULL
ea	NULL
e	NULL
ena	NULL
a	NULL
ne	NULL
ea	NULL
nees	NULL
GATA-1/AP-2	NULL
NF-	NULL
!	NULL

L6	NULL
U	NULL
_	NULL
-573	NULL
cacATGGGGTGAAGAAAGGGGGGTGACTTGAATGAAGGTGGAGGAGAAAAATGAGAACCAAGAAAGCAAAGGATCGAGAAGCTCAGTGTGGCAGCAG	NULL
OCT-2A	NULL
NF-IL6	NULL
c-ETS	NULL
U	NULL
_	NULL
-476	NULL
-CTCTCTTCCCCTCCTGAGAGAGTCAAAGGGTGGCATCAGGGACTCATGATCCATGGTTGTGGAAGCCTCATGTCACACTGGATGTCACATGAGGTG	NULL
B	NULL
uus	NULL
s	NULL
e	NULL
s	NULL
k	NULL
e	NULL
e	NULL
ea	NULL
e	NULL
e	NULL
ens	NULL
v	NULL
nn	NULL
nas	NULL
n	NULL
n	NULL
ba	NULL
s	NULL
e	NULL
non	NULL
ba	NULL
e	NULL
e	NULL
na	NULL
e	NULL
e	NULL
nn	NULL
nas	NULL
n	NULL
nae	NULL
n	NULL
n	NULL
nna	NULL
e	NULL
nnn	NULL
a	NULL
n	NULL
e	NULL
n	NULL
na	NULL
a	NULL
nn	NULL
nas	NULL
e	NULL
e	NULL
n	NULL
na	NULL
e	NULL
en	NULL
na	NULL
e	NULL
e	NULL
e	NULL
nnn	NULL
e	NULL
ena	NULL
a	NULL
n	NULL
n	NULL
nas	NULL
ea	NULL
GR/PR	NULL
C_	NULL
-380	NULL
ccateeAracACAGTGACCACCCCACCTCATTTCCTTTACAGCTTCCGTGGTGGGCCATGGCAGTGAACA-CCTTCAGGCATGTCTACGGCGGAATAT	NULL
e	NULL
eae	NULL
T	NULL
...	NULL
.G..	NULL
C/EBP	NULL
/AP-3	NULL
(	NULL
_	NULL
-284	NULL
cTeaATTCAGGCTGGTGGCAGGAGACAACACAACCACGTTTTCTTTTATGCATGCATTTGGTTTAATTGACACATTAACCACAGACAAAGGGGTAAA	NULL
e	NULL
GT	NULL
...	NULL
...	NULL
...	NULL
..	NULL
eee	NULL
keer	NULL
ee	NULL
nea	NULL
ee	NULL
reese	NULL
ee	NULL
ee	NULL
een	NULL
nen	NULL
en	NULL
nen	NULL
ee	NULL
e	NULL
nre	NULL
en	NULL
ea	NULL
ee	NULL
ene	NULL
ees	NULL
IRF-1	NULL
/IRF-2	NULL
E1	NULL
&	NULL
-187	NULL
ceccacarceceTTAGGTTAGTATGAACAGGGAAAAGGGACTTTTTTTTTTTTTTTTAAGAAAAATAAAAGCATCAGTATTGCAAAGACTTTCCATG	NULL
NF-kB	NULL
/	NULL
c-REL	NULL
-	NULL
TCF2	NULL
«	NULL
/	NULL
ETS-1	NULL
/	NULL
PEA3	NULL
TATA	NULL
f	NULL
-90	NULL
Boo	NULL
azz	NULL
T.	NULL
ak	NULL
e	NULL
sev	NULL
e	NULL
ees	NULL
e	NULL
e	NULL
e	NULL
nes	NULL
ee	NULL
eee	NULL
e	NULL
e	NULL
eas	NULL
Take	NULL
.	NULL

seee	NULL
ee	NULL
ks	NULL
e	NULL
ees	NULL
Tul	NULL
...	NULL
.	NULL

.e	NULL
...	NULL
e.	NULL
}	NULL
Ave	NULL
es	NULL
kee	NULL
es	NULL
ee	NULL
ees	NULL
a	NULL
e	NULL
vea	NULL
C	NULL
...	NULL
...	NULL
.	NULL

O	NULL
+8	NULL
CTTGCACAGCTCAGCAGGACCTCAGCC	NULL
[	NULL
TGAGACTTCTC	NULL
transcriptional	NULL
start	NULL
B	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
uue	NULL
.	NULL

v	NULL
e	NULL
eee	NULL
e	NULL
ehe	NULL
e	NULL
e	NULL
ee	NULL
ek	NULL
ees	NULL
translational	NULL
start	NULL
FIGURE	NULL
1	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
immediate	NULL
upstream	NULL
regions	NULL
of	NULL
the	NULL
two	NULL
SCM-1	NULL
genes	NULL
.	NULL

The	NULL
numbering	NULL
is	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcriptional	NULL
initiation	NULL
site	NULL
determined	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Dots	NULL
in	NULL
the	NULL
sequence	NULL
of	NULL
SCM-1	NULL
(	NULL
represent	NULL
nucleotides	NULL
identical	NULL
with	NULL
those	NULL
of	NULL
SCM-1	NULL
«	NULL
.	NULL

Potential	NULL
regulatory	NULL
elements	NULL
revealed	NULL
by	NULL
computer	NULL
analysis	NULL
are	NULL
indicated	NULL
by	NULL
overlines	NULL
with	NULL
names	NULL
.	NULL

The	NULL
E1	NULL
site	NULL
(	NULL
-108	NULL
to	NULL
-83	NULL
)	NULL
is	NULL
boxed	NULL
.	NULL

healthy	NULL
donors	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
PHA	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
;	NULL
1/100	NULL
)	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
of	NULL
rIL-2	NULL
(	NULL
Shionogi	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

After	NULL
2	NULL
days	NULL
,	NULL
lymphocytes	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
of	NULL
IL-2	NULL
.	NULL

After	NULL
overnight	NULL
culture	NULL
,	NULL
CD4*	NULL
and	NULL
CD8*	NULL
T	NULL
cells	NULL
were	NULL
negatively	NULL
selected	NULL
using	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
,	NULL
Great	NULL
Neck	NULL
,	NULL
NY	NULL
)	NULL
after	NULL
incubation	NULL
with	NULL
anti-CD8	NULL
or	NULL
anti-CD4	NULL
(	NULL
Dako	NULL
,	NULL
Carpenteria	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
that	NULL
,	NULL
whole	NULL
and	NULL
selected	NULL
populations	NULL
were	NULL
expanded	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
of	NULL
IL-2	NULL
for	NULL
1	NULL
wk	NULL
and	NULL
used	NULL
for	NULL
transfection	NULL
experiments	NULL
.	NULL

Flow	NULL
cyto-metric	NULL
analysis	NULL
routinely	NULL
demonstrated	NULL
that	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cell	NULL
populations	NULL
were	NULL
>	NULL
80	NULL
and	NULL
>	NULL
90	NULL
%	NULL
pure	NULL
,	NULL
respectively	NULL
.	NULL

Plasmid	NULL
construction	NULL
The	NULL
promoterless	NULL
luciferase	NULL
plasmid	NULL
pGV-B	NULL
was	NULL
purchased	NULL
from	NULL
Toyo	NULL
Ink	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
a	NULL
series	NULL
of	NULL
5	NULL
``	NULL
deletions	NULL
,	NULL
DNA	NULL
fragments	NULL
were	NULL
amplified	NULL
from	NULL
the	NULL
SCM-1	NULL
«	NULL
genomic	NULL
template	NULL
by	NULL
PCR	NULL
using	NULL
a	NULL
3	NULL
'	NULL
oligonucleotide	NULL
tailed	NULL
with	NULL
an	NULL
Xho	NULL
!	NULL

site	NULL
(	NULL
5'-CTCGAGCTGTGCAAGGAGA-3	NULL
'	NULL
)	NULL
and	NULL
5	NULL
``	NULL
oligonucleotides	NULL
of	NULL
20	NULL
bp	NULL
tailed	NULL
with	NULL
a	NULL
Mizl	NULL
site	NULL
and	NULL
beginning	NULL
at	NULL
-669	NULL
,	NULL
-497	NULL
,	NULL
-279	NULL
,	NULL
-127	NULL
,	NULL
-117	NULL
,	NULL
-108	NULL
,	NULL
-98	NULL
,	NULL
-83	NULL
,	NULL
-62	NULL
,	NULL
-42	NULL
,	NULL
and	NULL
-32	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
Miul	NULL
and	NULL
Xhol	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
M/ul	NULL
and	NULL
Xhol	NULL
sites	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
pGV-B	NULL
.	NULL

Base	NULL
substitutions	NULL
were	NULL
also	NULL
introduced	NULL
using	NULL
PCR	NULL
.	NULL

An	NULL
N-terminally	NULL
truncated	NULL
464-aa	NULL
form	NULL
of	NULL
NF-ATp	NULL
(	NULL
12	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
domains	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
for	NULL
formation	NULL
of	NULL
a	NULL
transcriptionally	NULL
active	NULL
complex	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
,	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
Nof	NULL
]	NULL
site	NULL
of	NULL
pEBV-His	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
increase	NULL
fidelity	NULL
,	NULL
all	NULL
PCR	NULL
amplifications	NULL
were	NULL
performed	NULL
using	NULL
Pfu	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
only	NULL
15	NULL
cycles	NULL
with	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
template	NULL
(	NULL
100	NULL
ng/reaction	NULL
)	NULL
.	NULL

All	NULL
PCR-derived	NULL
sequences	NULL
were	NULL
checked	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Transfection	NULL
and	NULL
luciferase	NULL
assay	NULL
pCMV-B-gal	NULL
,	NULL
a	NULL
CMV	NULL
promoter-driven	NULL
-galactosidase	NULL
(	NULL
B-gal	NULL
)	NULL
construct	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

It	NULL
was	NULL
used	NULL
for	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
.	NULL

For	NULL
transfection	NULL
of	NULL
each	NULL
cell	NULL
line	NULL
,	NULL
~1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
30	NULL
pug	NULL
of	NULL
a	NULL
test	NULL
plasmid	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
pCMV-B-gal	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
PBS	NULL
and	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
250	NULL
V/500	NULL
F.	NULL
For	NULL
transfection	NULL
of	NULL
primary	NULL
T	NULL
lymphocytes	NULL
,	NULL
we	NULL
followed	NULL
the	NULL
procedure	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
about	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
100	NULL
ug	NULL
of	NULL
a	NULL
test	NULL
plasmid	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
pCMV-B-gal	NULL
in	NULL
0.8	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
of	NULL
IL-2	NULL
and	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
350	NULL
V/960	NULL
wE	NULL
.	NULL

Transfected	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
and	NULL
20	NULL
%	NULL
FCS	NULL
for	NULL
18	NULL
h.	NULL
Transfected	NULL
lymphocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
20	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
of	NULL
IL-2	NULL
for	NULL
18	NULL
h.	NULL
After	NULL
that	NULL
,	NULL
cell	NULL
cultures	NULL
were	NULL
divided	NULL
and	NULL
further	NULL
treated	NULL
without	NULL
or	NULL
with	NULL
PHA	NULL
(	NULL
1/100	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
30	NULL
ng/ml	NULL
;	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
or	NULL
with	NULL
anti-CD3	NULL
(	NULL
OKT3	NULL
)	NULL
that	NULL
was	NULL
immobilized	NULL
on	NULL
plastic	NULL
dishes	NULL
by	NULL
incubation	NULL
at	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
overnight	NULL
.	NULL

After	NULL
additional	NULL
24-h	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
for	NULL
luciferase	NULL
assay	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
obtained	NULL
by	NULL
centrifugation	NULL
.	NULL

After	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
by	NULL
B-gal	NULL
as-say	NULL
,	NULL
luciferase	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
PicaGene	NULL
kit	NULL
(	NULL
Toyo	NULL
Inki	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Light	NULL
units	NULL
were	NULL
measured	NULL
on	NULL
a	NULL
luminometer	NULL
(	NULL
Lumat	NULL
LB9501	NULL
,	NULL
Berthold	NULL
,	NULL
Wildbad	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
The	NULL
following	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
using	NULL
a	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Cyclon	NULL
Plus	NULL
DNA	NULL
Synthesizer	NULL
,	NULL
MilliGene/Biosearch	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
:	NULL
E1	NULL
,	NULL
5	NULL
``	NULL
-ATTGCAAAGACTITCCATGATCCTA-3	NULL
'	NULL
;	NULL
muB1	NULL
,	NULL
5'-ATTGCAAAGACTCTAGATGATCCTA-3	NULL
'	NULL
;	NULL
NF-AT	NULL
;	NULL
;	NULL
,	NULL
,	NULL
5-GGGGAG	NULL
GAAAAACTGTITCATACAGAAGGCGT-3	NULL
'	NULL
;	NULL
AP-1y	NULL
,	NULL
,	NULL
5'-TICCAAA	NULL
GAGTCATCAG-3	NULL
'	NULL
;	NULL
and	NULL
a	NULL
series	NULL
of	NULL
mutated	NULL
E1	NULL
oligonucleotides	NULL
with	NULL
2-bp	NULL
substitutions	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5E	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
purchased	NULL
from	NULL
Promega	NULL
:	NULL
Oct-1	NULL
,	NULL
5	NULL
``	NULL
-TGTCGAATGCAAATCACTAGAA-3	NULL
'	NULL
;	NULL
and	NULL
SP-1	NULL
,	NULL
5-ATTCGATCGGGGCGGGGCGAGC-3	NULL
'	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
without	NULL
or	NULL
with	NULL
PHA	NULL
(	NULL
1/100	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
4	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
100	NULL
ng/ml	NULL
;	NULL
Sandoz	NULL
Research	NULL
Institute	NULL
,	NULL
Hanover	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
were	NULL
end	NULL
labeled	NULL
using	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-NF-ATp	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-NF-ATe	NULL
and	NULL
anti-NF-ATx	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
3	NULL
pug/reaction	NULL
)	NULL
were	NULL
incubated	NULL
without	NULL
or	NULL
with	NULL
competitors	NULL
or	NULL
anti-NF-ATp	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
mixed	NULL
with	NULL
°°P-labeled	NULL
probes	NULL
(	NULL
~3	NULL
xX	NULL
10+	NULL
cpm/ng	NULL
,	NULL
1	NULL
ng/reaction	NULL
)	NULL
for	NULL
another	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
a	NULL
solution	NULL
consisting	NULL
of	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Ficoll	NULL
,	NULL
and	NULL
2	NULL
ug/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Bound	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
probes	NULL
by	NULL
elec-trophoresis	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
,	NULL
and	NULL
complexes	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
3297	NULL
A	NULL
C	NULL
_	NULL
100	NULL
_	NULL
1004	NULL
-	NULL
Q	NULL
seve	NULL
>	NULL
BM	NULL
PHA+PMA	NULL
€	NULL
{	NULL
|	NULL
FAsomi1ic	NULL
s	NULL
80717	NULL
(	NULL
5	NULL
so	NULL
-	NULL
6	NULL
g	NULL
M	NULL
soms	NULL
I	NULL
o	NULL
_	NULL
]	NULL
®	NULL
60	NULL
8	NULL
64	NULL
a	NULL
8	NULL
4	NULL
@	NULL
'S	NULL
us-	NULL
8	NULL
40	NULL
3	NULL
40	NULL
3	NULL
se	NULL
0	NULL
]	NULL
&	NULL
°	NULL
204	NULL
20	NULL
0~	NULL
o	NULL
--	NULL
«	NULL
CD3	NULL
-	NULL
PHA+PMA	NULL
HPB-	NULL
-	NULL
BALLA	NULL
-	NULL
Hela	NULL
-	NULL
Jurkat	NULL
-	NULL
PEER	NULL
ALL	NULL
B	NULL
D	NULL
F	NULL
JES	NULL
120	NULL
30-	NULL
{	NULL
A	NULL
-	NULL
3	NULL
>	NULL
1	NULL
e	NULL
11.2	NULL
3	NULL
100	NULL
4	NULL
-e-	NULL
PHA+PMA	NULL
g	NULL
g	NULL
so	NULL
1	NULL
o	NULL
-	NULL
no	NULL
treatment	NULL
2	NULL
207	NULL
0	NULL
E	NULL
C	NULL
t	NULL
&	NULL
_	NULL
s	NULL
607	NULL
o	NULL
(	NULL
l	NULL
2	NULL
o-	NULL
253	NULL
40	NULL
-	NULL
]	NULL
a	NULL
|	NULL
3	NULL
a	NULL
ze	NULL
201	NULL
0	NULL
1.2	NULL
0	NULL
3	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
U	NULL
PBL	NULL
|	NULL
PBL	NULL
|	NULL
co4+|	NULL
cDs+	NULL
804	NULL
(	NULL
lug/mic	NULL
100800	NULL
pGV-B	NULL
~669	NULL
luc	NULL
FIGURE	NULL
2	NULL
.	NULL

Cell	NULL
type-specific	NULL
and	NULL
stimulation-dependent	NULL
activation	NULL
of	NULL
the	NULL
SCM-1	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
luciferase	NULL
gene	NULL
without	NULL
promoter	NULL
(	NULL
pGV-B	NULL
)	NULL
or	NULL
those	NULL
with	NULL
the	NULL
~7-kb	NULL
5	NULL
``	NULL
flanking	NULL
regions	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
(	NULL
SCM-1a	NULL
and	NULL
After	NULL
stimulation	NULL
without	NULL
or	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
or	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
conducted	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
SEM	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
highest	NULL
activity	NULL
obtained	NULL
.	NULL

B	NULL
,	NULL
Primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
were	NULL
expanded	NULL
by	NULL
PHA	NULL
plus	NULL
IL-2	NULL
.	NULL

Unfractionated	NULL
T	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
or	NULL
those	NULL
enriched	NULL
for	NULL
CD4	NULL
*	NULL
or	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
without	NULL
promoter	NULL
(	NULL
pGV-B	NULL
)	NULL
or	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
with	NULL
the	NULL
~0.7-kb	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
SCM-1a	NULL
«	NULL
gene	NULL
(	NULL
-699/luc	NULL
)	NULL
.	NULL

After	NULL
mock	NULL
treatment	NULL
(	NULL
-	NULL
;	NULL
open	NULL
column	NULL
)	NULL
or	NULL
treatment	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
filled	NULL
column	NULL
)	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
conducted	NULL
in	NULL
duplicate	NULL
.	NULL

The	NULL
mean	NULL
relative	NULL
activity	NULL
to	NULL
that	NULL
of	NULL
pGV-B-transfected	NULL
and	NULL
unstimulated	NULL
PBL	NULL
is	NULL
shown	NULL
.	NULL

C	NULL
,	NULL
The	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
with	NULL
the	NULL
~0.7-kb	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
SCM-1a	NULL
gene	NULL
(	NULL
-699/luc	NULL
)	NULL
.	NULL

After	NULL
mock	NULL
treatment	NULL
(	NULL
-	NULL
;	NULL
open	NULL
column	NULL
)	NULL
or	NULL
treatment	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
closed	NULL
column	NULL
)	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
SEM	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
highest	NULL
activity	NULL
.	NULL

D	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
with	NULL
the	NULL
~0.7-kb	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
SCM-1	NULL
«	NULL
gene	NULL
(	NULL
-699/luc	NULL
)	NULL
.	NULL

After	NULL
mock	NULL
treatment	NULL
(	NULL
open	NULL
circle	NULL
)	NULL
or	NULL
treatment	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
closed	NULL
circle	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
indicated	NULL
concentrations	NULL
of	NULL
CsA	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
uciferase	NULL
assay	NULL
was	NULL
conducted	NULL
in	NULL
duplicate	NULL
.	NULL

The	NULL
mean	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
highest	NULL
activity	NULL
.	NULL

Yeast	NULL
one-hybrid	NULL
assay	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
of	NULL
SCM-1a	NULL
and	NULL
SCM-1	NULL
in	NULL
the	NULL
upstream	NULL
of	NULL
the	NULL
The	NULL
yeast	NULL
one-hybrid	NULL
assay	NULL
(	NULL
17	NULL
)	NULL
was	NULL
conducted	NULL
by	NULL
using	NULL
Matchmaker	NULL
One-	NULL
promo-terléss	NULL
luciferase	NULL
gene	NULL
pGV-B	NULL
.	NULL

EVC	NULL
tranSfefCted	NULL
these	NULL
reporter	NULL
Hybrid	NULL
System	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
concatemer	NULL
con-	NULL
plasmids	NULL
into	NULL
Jurkat	NULL
,	NULL
a	NULL
human	NULL
CD4	NULL
``	NULL
T	NULL
cell	NULL
line	NULL
capable	NULL
of	NULL
ex-sisting	NULL
of	NULL
six	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
E1	NULL
element	NULL
was	NULL
linked	NULL
to	NULL
a	NULL
low	NULL
activity	NULL
pressing	NULL
SCM-1	NULL
(	NULL
8	NULL
)	NULL
.	NULL

At	NULL
18	NULL
h	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
stimu-promoter	NULL
directing	NULL
expression	NULL
of	NULL
HIS3	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
was	NULL
inte-	NULL
lated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
or	NULL
PHA	NULL
and	NULL
PMA	NULL
,	NULL
and	NULL
cell	NULL
ex-grated	NULL
into	NULL
the	NULL
recipient	NULL
yeast	NULL
genome	NULL
.	NULL

This	NULL
yeast	NULL
strain	NULL
was	NULL
transformed	NULL
tracts	NULL
were	NULL
prepared	NULL
for	NULL
luciferase	NULL
assay	NULL
after	NULL
additional	NULL
24-h	NULL
with	NULL
a	NULL
Jurkat	NULL
cDNA	NULL
library	NULL
expressing	NULL
fusion	NULL
proteins	NULL
with	NULL
the	NULL
target-	NULL
e	NULL
.	NULL

.	NULL

independent	NULL
Gal4	NULL
activation	NULL
domain	NULL
and	NULL
plated	NULL
on	NULL
medium	NULL
lacking	NULL
histi-	NULL
culture	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
the	NULL
~0.7-kb	NULL
5°	NULL
flanking	NULL
regions	NULL
of	NULL
dine	NULL
.	NULL

HIS*	NULL
colonies	NULL
were	NULL
isolated	NULL
,	NULL
plasmids	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
inserts	NULL
the	NULL
SCM-1a	NULL
@	NULL
and	NULL
genes	NULL
showed	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
basal	NULL
were	NULL
sequenced	NULL
.	NULL

The	NULL
same	NULL
reporter	NULL
system	NULL
directing	NULL
expression	NULL
of	NULL
lacZ	NULL
_	NULL
expression	NULL
,	NULL
but	NULL
were	NULL
strongly	NULL
induced	NULL
upon	NULL
stimulation	NULL
with	NULL
anti-was	NULL
used	NULL
to	NULL
test	NULL
positive	NULL
clones	NULL
(	NULL
17	NULL
)	NULL
.	NULL

CD3	NULL
or	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
~0.7-kb	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
of	NULL
SCM-1	NULL
genes	NULL
contained	NULL
essential	NULL
regulatory	NULL
elements	NULL
for	NULL
the	NULL
ac	NULL
Resqlts	NULL
.	NULL

,	NULL
.	NULL

.	NULL

tivation-dependent	NULL
gene	NULL
expression	NULL
.	NULL

Because	NULL
these	NULL
~0.7-kb	NULL
5	NULL
'	NULL
Functional	NULL
analysis	NULL
of	NULL
the	NULL
5°	NULL
flanking	NULL
regions	NULL
of	NULL
the	NULL
franking	NULL
regions	NULL
are	NULL
97	NULL
%	NULL
identical	NULL
at	NULL
the	NULL
DNA	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
our	NULL
SCM-1	NULL
genes	NULL
subsequent	NULL
experiments	NULL
were	NULL
conducted	NULL
using	NULL
the	NULL
SCM-1	NULL
«	NULL
gene	NULL
Previously	NULL
,	NULL
we	NULL
have	NULL
described	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
highly	NULL
homol-	NULL
promoter	NULL
.	NULL

ogous	NULL
SCM-1	NULL
genes	NULL
encoding	NULL
SCM-1	NULL
«	NULL
and	NULL
SCM-1	NULL
3	NULL
in	NULL
the	NULL
human	NULL
In	NULL
Fig	NULL
.	NULL

2B	NULL
we	NULL
transfected	NULL
the	NULL
reporter	NULL
plasmid	NULL
with	NULL
the	NULL
~0.7-kb	NULL
genome	NULL
(	NULL
8	NULL
)	NULL
.	NULL

These	NULL
two	NULL
genes	NULL
are	NULL
similarly	NULL
inducible	NULL
upon	NULL
cell	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
SCM-1	NULL
«	NULL
gene	NULL
(	NULL
-669/luc	NULL
)	NULL
into	NULL
total	NULL
T	NULL
activation	NULL
(	NULL
8	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
~0.7-kb	NULL
5	NULL
'	NULL
flanking	NULL
se-	NULL
cells	NULL
,	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Upon	NULL
treatment	NULL
with	NULL
PHA	NULL
quences	NULL
of	NULL
the	NULL
and	NULL
SCM-1	NULL
$	NULL
B	NULL
genes	NULL
are	NULL
97	NULL
%	NULL
identical	NULL
.	NULL

and	NULL
PMA	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
was	NULL
strongly	NULL
induced	NULL
in	NULL
primary	NULL
hu-Computer	NULL
analysis	NULL
reveals	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
regulatory	NULL
ele-	NULL
man	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
higher	NULL
level	NULL
of	NULL
induction	NULL
was	NULL
consis-ments	NULL
.	NULL

We	NULL
first	NULL
tested	NULL
whether	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
of	NULL
the	NULL
tently	NULL
seen	NULL
in	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
~90	NULL
%	NULL
purity	NULL
)	NULL
than	NULL
in	NULL
CD4	NULL
*	NULL
(	NULL
~80	NULL
%	NULL
SCM-1a	NULL
and	NULL
genes	NULL
were	NULL
similarly	NULL
inducible	NULL
by	NULL
cell	NULL
ac-	NULL
purity	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
~0.7-kb	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
SCM-1	NULL
«	NULL
gene	NULL
tivation	NULL
.	NULL

We	NULL
generated	NULL
reporter	NULL
genes	NULL
by	NULL
introducing	NULL
the	NULL
~0.7-kb	NULL
was	NULL
capable	NULL
of	NULL
regulating	NULL
activation-dependent	NULL
gene	NULL
expression	NULL
in	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3298	NULL
REGULATION	NULL
OF	NULL
SCM-1/LYMPHOTACTIN	NULL
BY	NULL
NF-AT	NULL
%	NULL
luc	NULL
activity	NULL
+1	NULL
o	NULL
50	NULL
100	NULL
FIGURE	NULL
3	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
_	NULL
669	NULL
SCM-1a	NULL
promoter	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
trans-	NULL
497	NULL
fected	NULL
with	NULL
a	NULL
series	NULL
of	NULL
the	NULL
luciferase	NULL
re-	NULL
279	NULL
porter	NULL
gene	NULL
constructs	NULL
shown	NULL
schemati-	NULL
cally	NULL
at	NULL
the	NULL
leff	NULL
After	NULL
mock	NULL
treatment	NULL
(	NULL
open	NULL
column	NULL
)	NULL
or	NULL
treatment	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
filled	NULL
column	NULL
)	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
per	NULL
formed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
SEM	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
right	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
-669/luc	NULL
construct	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
.	NULL

primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
with	NULL
preference	NULL
for	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
populations	NULL
might	NULL
be	NULL
due	NULL
in	NULL
part	NULL
to	NULL
the	NULL
relatively	NULL
low	NULL
purity	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
~80	NULL
%	NULL
)	NULL
and/or	NULL
to	NULL
human	NULL
equivalents	NULL
of	NULL
the	NULL
murine	NULL
NK1.1~*	NULL
CD4	NULL
``	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
mentioned	NULL
to	NULL
express	NULL
lymphotactin/	NULL
SCM-1	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
we	NULL
further	NULL
tested	NULL
the	NULL
cell	NULL
type-specific	NULL
promoter	NULL
activity	NULL
by	NULL
using	NULL
five	NULL
human	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
CMV-B-gal	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
transfection	NULL
efficiency	NULL
by	NULL
B-gal	NULL
activity	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
endogenous	NULL
SCM-1	NULL
genes	NULL
(	NULL
8	NULL
)	NULL
,	NULL
the	NULL
treatment	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
strongly	NULL
activated	NULL
the	NULL
promoter	NULL
in	NULL
Jurkat	NULL
(	NULL
a	NULL
CD4	NULL
single-positive	NULL
T	NULL
cell	NULL
line	NULL
)	NULL
and	NULL
PEER	NULL
(	NULL
a	NULL
double-negative	NULL
78	NULL
T	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
HPB-ALL	NULL
(	NULL
a	NULL
double-positive	NULL
T	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
BALL-1	NULL
(	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
or	NULL
HeLa	NULL
(	NULL
an	NULL
epithelial	NULL
cell	NULL
line	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
~0.7-kb	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
SCM-1	NULL
«	NULL
gene	NULL
is	NULL
functional	NULL
only	NULL
in	NULL
certain	NULL
T	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
capable	NULL
of	NULL
expressing	NULL
the	NULL
endogenous	NULL
SCM-1	NULL
genes	NULL
upon	NULL
activation	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
the	NULL
stimulation-dependent	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
Jurkat	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
CsA	NULL
completely	NULL
abrogated	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
by	NULL
PHA	NULL
and	NULL
PMA	NULL
with	NULL
an	NULL
ICs	NULL
,	NULL
of	NULL
about	NULL
1	NULL
ng/ml	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
clearly	NULL
demonstrated	NULL
that	NULL
the	NULL
~0.7-kb	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
contain	NULL
major	NULL
cis-acting	NULL
elements	NULL
that	NULL
regulate	NULL
the	NULL
activation-dependent	NULL
,	NULL
cell	NULL
type-specific	NULL
,	NULL
and	NULL
CsA-sensitive	NULL
expression	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
To	NULL
determine	NULL
the	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
SCM-1a	NULL
«	NULL
gene	NULL
,	NULL
we	NULL
transfected	NULL
a	NULL
series	NULL
of	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
with	NULL
progressively	NULL
deleted	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
all	NULL
the	NULL
plasmids	NULL
showed	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

Upon	NULL
PHA	NULL
and	NULL
PMA	NULL
stimulation	NULL
,	NULL
-669/luec	NULL
and	NULL
-497/luc	NULL
induced	NULL
luciferase	NULL
activity	NULL
by	NULL
about	NULL
30-fold	NULL
;	NULL
-279/luc	NULL
,	NULL
-117/luec	NULL
and	NULL
-108/lue	NULL
induced	NULL
luciferase	NULL
activity	NULL
by	NULL
about	NULL
15-fold	NULL
;	NULL
-98/luc	NULL
,	NULL
-83/luc	NULL
,	NULL
and	NULL
-62/luc	NULL
induced	NULL
luciferase	NULL
activity	NULL
by	NULL
about	NULL
3-fold	NULL
;	NULL
-42/lue	NULL
and	NULL
-32/luc	NULL
induced	NULL
luciferase	NULL
activity	NULL
by	NULL
<	NULL
2-fold	NULL
.	NULL

From	NULL
these	NULL
results	NULL
,	NULL
at	NULL
least	NULL
three	NULL
regions	NULL
(	NULL
-497	NULL
to	NULL
-279	NULL
,	NULL
-108	NULL
to	NULL
-98	NULL
,	NULL
and	NULL
-62	NULL
to	NULL
-42	NULL
)	NULL
appeared	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
full	NULL
inducibility	NULL
of	NULL
the	NULL
SCM-1a	NULL
promoter	NULL
upon	NULL
treatment	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
,	NULL
and	NULL
the	NULL
region	NULL
between	NULL
-108	NULL
and	NULL
-98	NULL
contained	NULL
a	NULL
major	NULL
cis-acting	NULL
element	NULL
.	NULL

A	NULL
close	NULL
inspection	NULL
of	NULL
the	NULL
sequence	NULL
in	NULL
and	NULL
around	NULL
this	NULL
region	NULL
revealed	NULL
a	NULL
sequence	NULL
(	NULL
-101	NULL
to	NULL
-92	NULL
)	NULL
that	NULL
contained	NULL
an	NULL
inverted	NULL
core	NULL
sequence	NULL
of	NULL
the	NULL
NF-AT	NULL
site	NULL
(	NULL
TTTCC	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Because	NULL
NF-AT	NULL
is	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
various	NULL
cytokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
activation-dependent	NULL
and	NULL
CsA-sensitive	NULL
Luciferase	NULL
P	NULL
?	NULL

Luciferase	NULL
B	NULL
_	NULL
stimulated	NULL
[	NULL
]	NULL
-	NULL
unstimulated	NULL
I	NULL
Luciferase	NULL
220	NULL
%	NULL
svao	NULL
[	NULL
Cacher	NULL
/no	NULL
mechanisms	NULL
(	NULL
10	NULL
)	NULL
,	NULL
our	NULL
subsequent	NULL
study	NULL
was	NULL
focused	NULL
on	NULL
this	NULL
element	NULL
.	NULL

For	NULL
the	NULL
sake	NULL
of	NULL
convenience	NULL
,	NULL
we	NULL
designated	NULL
the	NULL
sequence	NULL
between	NULL
-108	NULL
and	NULL
-83	NULL
as	NULL
element	NULL
1	NULL
(	NULL
E1	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
in	NULL
El	NULL
We	NULL
first	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
NFE-AT	NULL
core	NULL
sequence	NULL
of	NULL
E1	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
-669-bp	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
with	NULL
the	NULL
wild-type	NULL
E1	NULL
or	NULL
a	NULL
mutated	NULL
El	NULL
with	NULL
three	NULL
base	NULL
substitutions	NULL
in	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
and	NULL
PEER	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
mutations	NULL
at	NULL
this	NULL
site	NULL
effectively	NULL
abrogated	NULL
the	NULL
stimulation-dependent	NULL
induction	NULL
of	NULL
the	NULL
reporter	NULL
driven	NULL
by	NULL
the	NULL
-669-bp	NULL
5	NULL
flanking	NULL
region	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
further	NULL
test	NULL
whether	NULL
E1	NULL
was	NULL
an	NULL
activation-inducible	NULL
and	NULL
CsA-sensitive	NULL
regulatory	NULL
element	NULL
,	NULL
we	NULL
constructed	NULL
an	NULL
artificial	NULL
reporter	NULL
plasmid	NULL
by	NULL
inserting	NULL
six	NULL
tandem	NULL
repeats	NULL
of	NULL
E1	NULL
in	NULL
the	NULL
upstream	NULL
of	NULL
the	NULL
-42/luc	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
the	NULL
reporter	NULL
driven	NULL
by	NULL
the	NULL
tandem	NULL
repeats	NULL
of	NULL
E1	NULL
was	NULL
indeed	NULL
induced	NULL
by	NULL
about	NULL
10-fold	NULL
in	NULL
transfected	NULL
Jurkat	NULL
by	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
induction	NULL
was	NULL
fully	NULL
abrogated	NULL
by	NULL
CsA	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
E1	NULL
containing	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
is	NULL
a	NULL
critical	NULL
regulatory	NULL
element	NULL
for	NULL
the	NULL
activation-dependent	NULL
and	NULL
CsA-sensitive	NULL
expression	NULL
of	NULL
the	NULL
SCM-1	NULL
promoter	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
El	NULL
To	NULL
demonstrate	NULL
specific	NULL
interactions	NULL
of	NULL
nuclear	NULL
proteins	NULL
with	NULL
El	NULL
,	NULL
EMSA	NULL
was	NULL
conducted	NULL
using	NULL
the	NULL
E1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
even	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
was	NULL
capable	NULL
of	NULL
forming	NULL
a	NULL
DNA-binding	NULL
complex	NULL
,	NULL
termed	NULL
complex	NULL
I	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
formed	NULL
a	NULL
higher	NULL
mobility	NULL
complex	NULL
,	NULL
termed	NULL
complex	NULL
II	NULL
,	NULL
with	NULL
concomitant	NULL
decrease	NULL
in	NULL
complex	NULL
I	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
blocked	NULL
by	NULL
the	NULL
wild-type	NULL
El	NULL
site	NULL
probe	NULL
(	NULL
wt	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
mutated	NULL
E1	NULL
site	NULL
probe	NULL
with	NULL
three	NULL
base	NULL
substitutions	NULL
in	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
(	NULL
mu	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

More-over	NULL
,	NULL
the	NULL
mutated	NULL
E1	NULL
site	NULL
probe	NULL
(	NULL
mu-E1	NULL
)	NULL
failed	NULL
to	NULL
form	NULL
any	NULL
complexes	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
Jurkat	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
of	NULL
the	NULL
E1	NULL
site	NULL
,	NULL
which	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
E1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
is	NULL
also	NULL
critical	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
complex	NULL
I	NULL
and	NULL
complex	NULL
II	NULL
.	NULL

EMSA	NULL
was	NULL
also	NULL
conducted	NULL
to	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
CsA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
the	NULL
nuclear	NULL
extract	NULL
of	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
only	NULL
formed	NULL
complex	NULL
I	NULL
and	NULL
failed	NULL
to	NULL
form	NULL
complex	NULL
II	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
shift	NULL
from	NULL
complex	NULL
I	NULL
to	NULL
complex	NULL
II	NULL
observed	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
was	NULL
effectively	NULL
blocked	NULL
by	NULL
CsA	NULL
treatment	NULL
.	NULL

This	NULL
further	NULL
supported	NULL
the	NULL
idea	NULL
that	NULL
the	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
AP-1	NULL
NFAT	NULL
NFATur-2	NULL
)	NULL
ATGAAACAGATTTTTCCTCTTTGGG	NULL
wt-E1	NULL
ATTGCAAAGACTTTCCATGATCCTA	NULL
mu-E1	NULL
ATTGCAAAGACTcTagATGATCCTA	NULL
B	NULL
%	NULL
luc	NULL
activity	NULL
Jurkat	NULL
MN	NULL
PHA+PMA	NULL
[	NULL
Z	NULL
]	NULL
unstimulated	NULL
PEER	NULL
~42/luc	NULL
4D	NULL
Luciferase	NULL
ct	NULL
cie	NULL
cee	NULL
ote	NULL
cg	NULL
cae	NULL
``	NULL
*	NULL
,	NULL
-	NULL
~E	NULL
{	NULL
Luciferase	NULL
%	NULL
luc	NULL
activity	NULL
0	NULL
20	NULL
-	NULL
40	NULL
60	NULL
80	NULL
100	NULL
120	NULL
[	NULL
-_-	NULL
]	NULL
no	NULL
treatment	NULL
RR	NULL
PHA+PMA	NULL
PHA+PMA+CsA	NULL
~42/luc	NULL
6X	NULL
(	NULL
E1	NULL
)	NULL
~42/luc	NULL
FIGURE	NULL
4	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
E1	NULL
site	NULL
in	NULL
the	NULL
SCM-1a	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
Alignment	NULL
of	NULL
the	NULL
distal	NULL
NF-AT	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
antisense	NULL
direction	NULL
)	NULL
with	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
binding	NULL
sites	NULL
indicated	NULL
,	NULL
wild-type	NULL
E1	NULL
with	NULL
a	NULL
potential	NULL
NF-AT	NULL
site	NULL
(	NULL
wt-E1	NULL
)	NULL
,	NULL
and	NULL
mutated	NULL
El	NULL
with	NULL
three	NULL
base	NULL
substitutions	NULL
in	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
(	NULL
mu-E1	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Jurkat	NULL
and	NULL
PEER	NULL
were	NULL
transfected	NULL
with	NULL
wild-type	NULL
-669/luc	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
-669/luc	NULL
with	NULL
mutated	NULL
E1	NULL
site	NULL
(	NULL
)	NULL
.	NULL

After	NULL
mock	NULL
treatment	NULL
or	NULL
treatment	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
SEM	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
-669/luc	NULL
in	NULL
Jurkat	NULL
stimulated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

C	NULL
,	NULL
An	NULL
artificial	NULL
reporter	NULL
gene	NULL
6xE1-42/luc	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
six	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
E1	NULL
site	NULL
in	NULL
the	NULL
upstream	NULL
of	NULL
-42/luc	NULL
.	NULL

Jurkat	NULL
was	NULL
transfected	NULL
with	NULL
-42/luc	NULL
or	NULL
6xE1-42/luc	NULL
.	NULL

After	NULL
mock	NULL
treatment	NULL
or	NULL
treatment	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
at	NULL
100	NULL
ng/ml	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
SEM	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
6xE1-42/luc	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
.	NULL

shift	NULL
from	NULL
complex	NULL
I	NULL
to	NULL
complex	NULL
II	NULL
was	NULL
required	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
.	NULL

By	NULL
cold	NULL
competition	NULL
experiments	NULL
,	NULL
we	NULL
next	NULL
analyzed	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
E1	NULL
in	NULL
complex	NULL
I	NULL
and	NULL
II	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
both	NULL
complexes	NULL
were	NULL
clearly	NULL
inhibited	NULL
by	NULL
the	NULL
E1	NULL
probe	NULL
at	NULL
10-fold	NULL
excess	NULL
and	NULL
by	NULL
the	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
probe	NULL
at	NULL
10-	NULL
to	NULL
30-fold	NULL
excess	NULL
(	NULL
15	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
IL-2	NULL
AP-1	NULL
site	NULL
probe	NULL
(	NULL
15	NULL
)	NULL
hardly	NULL
affected	NULL
complex	NULL
I	NULL
even	NULL
at	NULL
a	NULL
100-fold	NULL
excess	NULL
.	NULL

This	NULL
probe	NULL
,	NULL
however	NULL
,	NULL
partially	NULL
inhibited	NULL
complex	NULL
II	NULL
at	NULL
a	NULL
30-	NULL
to	NULL
100-fold	NULL
excess	NULL
.	NULL

For	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
EMSA	NULL
was	NULL
also	NULL
conducted	NULL
using	NULL
the	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
probe	NULL
(	NULL
15	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
a	NULL
complex	NULL
was	NULL
formed	NULL
only	NULL
with	NULL
the	NULL
extract	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
.	NULL

Furthermore	NULL
,	NULL
3299	NULL
this	NULL
complex	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
probe	NULL
(	NULL
and	NULL
the	NULL
E1	NULL
site	NULL
probe	NULL
)	NULL
as	NULL
well	NULL
as	NULL
by	NULL
the	NULL
IL-2	NULL
AP-1	NULL
site	NULL
probe	NULL
(	NULL
10	NULL
,	NULL
15	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
both	NULL
complexes	NULL
contained	NULL
proteins	NULL
related	NULL
to	NULL
NF-AT	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
complex	NULL
II	NULL
might	NULL
contain	NULL
a	NULL
cofactor	NULL
related	NULL
to	NULL
the	NULL
AP-1	NULL
family	NULL
.	NULL

However	NULL
,	NULL
there	NULL
is	NULL
no	NULL
consensus	NULL
AP-1	NULL
site	NULL
as	NULL
defined	NULL
by	NULL
T	NULL
(	NULL
T/G	NULL
)	NULL
ANT	NULL
(	NULL
A/C	NULL
)	NULL
A	NULL
(	NULL
18	NULL
)	NULL
in	NULL
or	NULL
around	NULL
the	NULL
E1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
further	NULL
define	NULL
the	NULL
critical	NULL
nucleotides	NULL
in	NULL
the	NULL
E1	NULL
site	NULL
that	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
constitutive	NULL
complex	NULL
I	NULL
and	NULL
inducible	NULL
complex	NULL
II	NULL
,	NULL
we	NULL
next	NULL
conducted	NULL
EMSA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mutated	NULL
E1	NULL
site	NULL
probes	NULL
with	NULL
scanning-type	NULL
2-bp	NULL
substitutions	NULL
as	NULL
cold	NULL
competitors	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

55	NULL
,	NULL
both	NULL
constitutive	NULL
complex	NULL
I	NULL
and	NULL
activation-inducible	NULL
complex	NULL
II	NULL
showed	NULL
essentially	NULL
identical	NULL
inhibition	NULL
patterns	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
same	NULL
nucleotide	NULL
sequence	NULL
in	NULL
the	NULL
E1	NULL
site	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
complexes	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
competition	NULL
by	NULL
M6	NULL
,	NULL
M7	NULL
,	NULL
and	NULL
M8	NULL
revealed	NULL
that	NULL
TTTCCA	NULL
corresponding	NULL
exactly	NULL
to	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
was	NULL
essential	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
complexes	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Cell	NULL
type-specific	NULL
formation	NULL
of	NULL
complex	NULL
II	NULL
By	NULL
using	NULL
the	NULL
E1	NULL
probe	NULL
,	NULL
EMSA	NULL
was	NULL
further	NULL
conducted	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
,	NULL
PEER	NULL
,	NULL
BALL-1	NULL
,	NULL
and	NULL
HPB-ALL	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Both	NULL
Jurkat	NULL
and	NULL
another	NULL
SCM-1	NULL
producer	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
PEER	NULL
(	NULL
8	NULL
)	NULL
,	NULL
formed	NULL
the	NULL
constitutive	NULL
complex	NULL
I	NULL
before	NULL
activation	NULL
and	NULL
the	NULL
inducible	NULL
complex	NULL
II	NULL
with	NULL
a	NULL
concomitant	NULL
decrease	NULL
or	NULL
disappearance	NULL
of	NULL
complex	NULL
I	NULL
upon	NULL
activation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

SCM-1-nonproducer	NULL
cell	NULL
lines	NULL
BALL-1	NULL
and	NULL
HPB-ALL	NULL
(	NULL
8	NULL
)	NULL
also	NULL
formed	NULL
complex	NULL
I	NULL
,	NULL
but	NULL
failed	NULL
to	NULL
form	NULL
complex	NULL
II	NULL
even	NULL
after	NULL
activation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
II	NULL
was	NULL
seen	NULL
only	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
SCM-1	NULL
producer	NULL
cell	NULL
lines	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

As	NULL
internal	NULL
controls	NULL
,	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
were	NULL
probed	NULL
with	NULL
the	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
probe	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
DNA-binding	NULL
complex	NULL
was	NULL
seen	NULL
only	NULL
with	NULL
extracts	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
and	NULL
HPB-ALL	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

NF-ATp	NULL
as	NULL
a	NULL
component	NULL
of	NULL
complexes	NULL
I	NULL
and	NULL
II	NULL
To	NULL
test	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NF-AT	NULL
family	NULL
proteins	NULL
in	NULL
complexes	NULL
I	NULL
and	NULL
II	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
polyclonal	NULL
anti-NF-ATp	NULL
was	NULL
examined	NULL
in	NULL
EMSA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
complex	NULL
I	NULL
formed	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
was	NULL
partially	NULL
supershifted	NULL
by	NULL
anti-NF-ATp	NULL
,	NULL
while	NULL
both	NULL
complex	NULL
I	NULL
and	NULL
complex	NULL
II	NULL
formed	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
activated	NULL
Jurkat	NULL
were	NULL
reduced	NULL
by	NULL
anti-NF-ATp	NULL
(	NULL
panel	NULL
El	NULL
)	NULL
.	NULL

A	NULL
faint	NULL
supershift	NULL
band	NULL
was	NULL
also	NULL
seen	NULL
.	NULL

The	NULL
discrepancy	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
anti-NF-ATp	NULL
on	NULL
complex	NULL
I	NULL
formed	NULL
by	NULL
unstimulated	NULL
Jurkat	NULL
and	NULL
that	NULL
formed	NULL
by	NULL
stimulated	NULL
Jurkat	NULL
was	NULL
unexpected	NULL
and	NULL
might	NULL
indicate	NULL
that	NULL
they	NULL
were	NULL
not	NULL
identical	NULL
.	NULL

As	NULL
internal	NULL
controls	NULL
,	NULL
the	NULL
same	NULL
Ab	NULL
was	NULL
shown	NULL
to	NULL
partially	NULL
supershift	NULL
the	NULL
IL-2	NULL
NF-AT	NULL
nuclear	NULL
complex	NULL
(	NULL
panel	NULL
NFAT	NULL
)	NULL
,	NULL
but	NULL
to	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
SP-1	NULL
nuclear	NULL
complex	NULL
(	NULL
panel	NULL
SP-1	NULL
)	NULL
.	NULL

We	NULL
further	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
various	NULL
anti-NF-AT	NULL
Abs	NULL
in	NULL
EMSA	NULL
using	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
PEER	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
anti-NF-ATp	NULL
again	NULL
partially	NULL
supershifted	NULL
complex	NULL
I	NULL
formed	NULL
by	NULL
the	NULL
nuclear	NULL
extract	NULL
of	NULL
unstimulated	NULL
PEER	NULL
.	NULL

It	NULL
also	NULL
slightly	NULL
reduced	NULL
and	NULL
faintly	NULL
supershifted	NULL
the	NULL
complex	NULL
II	NULL
formed	NULL
by	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
stimulated	NULL
PEER	NULL
even	NULL
though	NULL
the	NULL
effect	NULL
was	NULL
less	NULL
dramatic	NULL
than	NULL
that	NULL
seen	NULL
with	NULL
Jurkat	NULL
.	NULL

No	NULL
such	NULL
effects	NULL
were	NULL
seen	NULL
with	NULL
anti-NF-ATc	NULL
and	NULL
anti-NF-ATx	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
support	NULL
that	NULL
both	NULL
complexes	NULL
I	NULL
and	NULL
II	NULL
contain	NULL
NF-ATp	NULL
or	NULL
some	NULL
proteins	NULL
immunologically	NULL
cross-reactive	NULL
with	NULL
anti-NF-ATp	NULL
.	NULL

Binding	NULL
of	NULL
NF-ATp	NULL
to	NULL
El	NULL
To	NULL
identify	NULL
proteins	NULL
binding	NULL
to	NULL
El	NULL
,	NULL
we	NULL
conducted	NULL
one-hybrid	NULL
screening	NULL
in	NULL
yeast	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
consisted	NULL
of	NULL
six	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3300	NULL
REGULATION	NULL
OF	NULL
SCM-1/LYMPHOTACTIN	NULL
BY	NULL
NF-AT	NULL
A	NULL
D	NULL
-	NULL
+	NULL
stimulation	NULL
probe	NULL
wt-E1	NULL
mu-E1	NULL
I	NULL
‘	NULL
lr—'——1	NULL
'	NULL
_	NULL
T	NULL
--	NULL
-	NULL
2	NULL
x	NULL
stimulation	NULL
_	NULL
-+	NULL
-	NULL
+	NULL
p54	NULL
Mi	NULL
_	NULL
d.	NULL
5	NULL
competitor	NULL
competitor	NULL
FP	NULL
``	NULL
-	NULL
wt	NULL
mU'-	NULL
wt	NULL
mu'-	NULL
-	NULL
7	NULL
wu	NULL
<	NULL
O	NULL
complex	NULL
I	NULL
n	NULL
-	NULL
<	NULL
NFAT	NULL
11	NULL
*-	NULL
¥	NULL
Vy	NULL
complex	NULL
II	NULL
'	NULL
|	NULL
-	NULL
>	NULL
T	NULL
wT	NULL
-	NULL
TTGCAAAGACTTTCCATGATCCTA	NULL
probe	NULL
B	NULL
probe	NULL
E1	NULL
timulation	NULL
_	NULL
sumu	NULL
al	NULL
+	NULL
+	NULL
competitor	NULL
M1	NULL
M2	NULL
M3	NULL
M4	NULL
MS	NULL
MS	NULL
CsA	NULL
_-	NULL
-	NULL
+	NULL
stimulation	NULL
-	NULL
+-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+-	NULL
+-	NULL
+	NULL
complex	NULL
I	NULL
complex	NULL
II	NULL
'	NULL
-me	NULL
C	NULL
==	NULL
-L	NULL
stimulation	NULL
4	NULL
a	NULL
o	NULL
i	NULL
1s	NULL
282	NULL
,	NULL
9	NULL
292	NULL
competitor	NULL
CQmPGUTOF	NULL
M7	NULL
MS	NULL
M9	NULL
M10	NULL
M11	NULL
M12	NULL
K	NULL
%	NULL
34	NULL
yg	NULL
°	NULL
X	NULL
XK	NULL
3	NULL
%	NULL
stimulation	NULL
-	NULL
$	NULL
-	NULL
+-	NULL
4+	NULL
-	NULL
$	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
w	NULL
w	NULL
®	NULL
ll	NULL
wt-E1	NULL
``	NULL
``	NULL
I	NULL
}	NULL
!	NULL

_	NULL
«	NULL
==	NULL
nPop	NULL
IY	NULL
.~	NULL
FIGURE	NULL
5	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
E1	NULL
site	NULL
.	NULL

A	NULL
,	NULL
The	NULL
E1	NULL
site	NULL
is	NULL
the	NULL
specific	NULL
target	NULL
site	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
mock	NULL
treated	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
using	NULL
*°P-labeled	NULL
wild-type	NULL
E1	NULL
or	NULL
mutated	NULL
E1	NULL
with	NULL
three	NULL
base	NULL
substitutions	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
binding	NULL
was	NULL
tested	NULL
by	NULL
cold	NULL
competitors	NULL
at	NULL
100-fold	NULL
molar	NULL
excess	NULL
as	NULL
indicated	NULL
.	NULL

Constitutive	NULL
complex	NULL
I	NULL
and	NULL
inducible	NULL
complex	NULL
II	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

B	NULL
,	NULL
The	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
inducible	NULL
complex	NULL
II	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
mock	NULL
treated	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
at	NULL
100	NULL
ng/ml	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
our	NULL
using	NULL
*°P-labeled	NULL
E1	NULL
.	NULL

Constitutive	NULL
complex	NULL
I	NULL
and	NULL
inducible	NULL
complex	NULL
II	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

C	NULL
,	NULL
Competition	NULL
of	NULL
constitutive	NULL
complex	NULL
I	NULL
and	NULL
inducible	NULL
complex	NULL
II	NULL
by	NULL
the	NULL
NF-AT	NULL
site	NULL
and	NULL
AP-1	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
mock	NULL
treated	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
using	NULL
*°P-labeled	NULL
E1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cold	NULL
competitors	NULL
.	NULL

D	NULL
,	NULL
The	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
is	NULL
the	NULL
specific	NULL
target	NULL
for	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
mock	NULL
treated	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
using	NULL
the	NULL
*°P-labeled	NULL
IL-2	NULL
NF-AT	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
indicated	NULL
cold	NULL
competitors	NULL
at	NULL
a	NULL
100-fold	NULL
excess	NULL
.	NULL

The	NULL
NF-AT	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

E	NULL
,	NULL
Mapping	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
E1	NULL
by	NULL
scanning	NULL
mutations	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
mock	NULL
treated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
+	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
with	NULL
**P-labeled	NULL
E1	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
each	NULL
one	NULL
of	NULL
the	NULL
cold	NULL
competitors	NULL
in	NULL
100-fold	NULL
excess	NULL
as	NULL
indicated	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Jurkat	NULL
PEER	NULL
BALL-1	NULL
HPB-ALL	NULL
-	NULL
extract	NULL
I	NULL
II	NULL
I	NULL
I	NULL
1	NULL
Loop	NULL
oe	NULL
os-	NULL
op	NULL
os	NULL
.	NULL

g	NULL
-	NULL
simulation	NULL
mpl	NULL
complex	NULL
I	NULL
5	NULL
complex	NULL
II	NULL
yoon	NULL
ei	NULL
i	NULL
.c	NULL
--	NULL
~¢Q	NULL
'	NULL
Q	NULL
f.—	NULL
<	NULL
bob	NULL
g	NULL
w	NULL
|	NULL
I1	NULL
111	NULL
FIGURE	NULL
6	NULL
.	NULL

Cell	NULL
type-specific	NULL
formation	NULL
of	NULL
inducible	NULL
complex	NULL
II	NULL
by	NULL
the	NULL
E1	NULL
site	NULL
probe	NULL
.	NULL

Jurkat	NULL
,	NULL
PEER	NULL
,	NULL
BALL-1	NULL
,	NULL
and	NULL
HPB-ALL	NULL
were	NULL
mock	NULL
treated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
+	NULL
PMA	NULL
(	NULL
+	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
using	NULL
*P-labeled	NULL
E1	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
IL-2	NULL
NF-AT	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Constitutive	NULL
complex	NULL
I	NULL
and	NULL
inducible	NULL
complex	NULL
II	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

tandem	NULL
repeats	NULL
of	NULL
E1	NULL
site	NULL
linked	NULL
to	NULL
a	NULL
low	NULL
activity	NULL
promoter	NULL
directing	NULL
His3	NULL
gene	NULL
expression	NULL
.	NULL

A	NULL
Jurkat	NULL
cDNA	NULL
library	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
clones	NULL
expressing	NULL
a	NULL
translational	NULL
fusion	NULL
with	NULL
the	NULL
Gal4	NULL
frans-activating	NULL
domain	NULL
was	NULL
transformed	NULL
into	NULL
a	NULL
his	NULL
yeast	NULL
strain	NULL
carrying	NULL
the	NULL
HIS3	NULL
reporter	NULL
plasmid	NULL
.	NULL

About	NULL
2	NULL
million	NULL
transformants	NULL
were	NULL
plated	NULL
on	NULL
the	NULL
medium	NULL
lacking	NULL
histidine	NULL
,	NULL
and	NULL
20	NULL
HIS*	NULL
colonies	NULL
were	NULL
isolated	NULL
.	NULL

By	NULL
partial	NULL
sequencing	NULL
,	NULL
we	NULL
found	NULL
that	NULL
10	NULL
of	NULL
20	NULL
positive	NULL
clones	NULL
were	NULL
NF-ATp	NULL
.	NULL

We	NULL
sequenced	NULL
one	NULL
NF-ATp	NULL
clone	NULL
and	NULL
found	NULL
that	NULL
it	NULL
encoded	NULL
an	NULL
N-terminally	NULL
truncated	NULL
NF-ATp	NULL
starting	NULL
from	NULL
the	NULL
amino	NULL
acid	NULL
position	NULL
at	NULL
401	NULL
and	NULL
consisting	NULL
of	NULL
521	NULL
aa	NULL
fused	NULL
in-frame	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
Gal4	NULL
.	NULL

To	NULL
measure	NULL
its	NULL
frans-activation	NULL
activity	NULL
,	NULL
we	NULL
conducted	NULL
B-gal	NULL
reporter	NULL
assay	NULL
in	NULL
yeast	NULL
using	NULL
a	NULL
reporter	NULL
construct	NULL
consisting	NULL
of	NULL
six	NULL
tandem	NULL
repeats	NULL
of	NULL
E1	NULL
site	NULL
linked	NULL
to	NULL
a	NULL
low	NULL
activity	NULL
promoter	NULL
directing	NULL
lacZ	NULL
gene	NULL
expression	NULL
(	NULL
17	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
the	NULL
NF-ATp-Gal4	NULL
fusion	NULL
protein	NULL
was	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
reporter	NULL
gene	NULL
by	NULL
about	NULL
20-fold	NULL
.	NULL

Thus	NULL
,	NULL
NF-ATp	NULL
is	NULL
capable	NULL
of	NULL
directly	NULL
binding	NULL
to	NULL
the	NULL
E1	NULL
site	NULL
in	NULL
yeast	NULL
.	NULL

Transfected	NULL
NF-ATp	NULL
enhances	NULL
SCM-1	NULL
promoter	NULL
activity	NULL
To	NULL
further	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
NF-ATp	NULL
on	NULL
the	NULL
SCM-1	NULL
promoter	NULL
,	NULL
we	NULL
cotransfected	NULL
-669/luc	NULL
with	NULL
wild-type	NULL
E1	NULL
site	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutated	NULL
E1	NULL
site	NULL
(	NULL
u	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
either	NULL
a	NULL
control	NULL
vector	NULL
or	NULL
a	NULL
vector	NULL
expressing	NULL
an	NULL
N-terminally	NULL
truncated	NULL
464-aa	NULL
functional	NULL
NF-ATp	NULL
(	NULL
12	NULL
)	NULL
into	NULL
Jurkat	NULL
and	NULL
BALL-1	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
transfection	NULL
of	NULL
functional	NULL
NF-ATp	NULL
into	NULL
Jurkat	NULL
significantly	NULL
augmented	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
SCM-1	NULL
promoter	NULL
with	NULL
the	NULL
wild-type	NULL
E1	NULL
site	NULL
,	NULL
but	NULL
not	NULL
that	NULL
with	NULL
the	NULL
mutated	NULL
El	NULL
site	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

Furthermore	NULL
,	NULL
transfection	NULL
of	NULL
NF-AT	NULL
'	NULL
p	NULL
into	NULL
the	NULL
SCM-1-nonproducer	NULL
BALL-1	NULL
strongly	NULL
induced	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
promoter	NULL
,	NULL
but	NULL
not	NULL
that	NULL
of	NULL
the	NULL
mutated	NULL
one	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

The	NULL
latter	NULL
observation	NULL
may	NULL
support	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
functional	NULL
NF-ATp	NULL
in	NULL
BALL-1	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
an	NULL
N-terminally	NULL
truncated	NULL
functional	NULL
NF-ATp	NULL
(	NULL
12	NULL
)	NULL
is	NULL
capable	NULL
of	NULL
frans-activating	NULL
the	NULL
SCM-1	NULL
promoter	NULL
through	NULL
the	NULL
E1	NULL
site	NULL
upon	NULL
cell	NULL
activation	NULL
.	NULL

3301	NULL
A	NULL
Jurkat	NULL
NFAT	NULL
E1	NULL
SP1	NULL
I	NULL
1	NULL
Co	NULL
l	NULL
Gu	NULL
G.	NULL
,	NULL
a	NULL
a.	NULL
o.	NULL
a.	NULL
a	NULL
i-	NULL
E	NULL
-	NULL
€	NULL
3	NULL
Es	NULL
£4	NULL
EL	NULL
EL	NULL
E	NULL
&	NULL
E	NULL
W	NULL
E	NULL
&	NULL
U	NULL
I	NULL
§	NULL
1	NULL
§4	NULL
%	NULL
1	NULL
$	NULL
%	NULL
-o	NULL
too-	NULL
=o	NULL
=~	NULL
o	NULL
+446	NULL
o	NULL
--	NULL
-	NULL
+++	NULL
woe	NULL
e	NULL
peg	NULL
an	NULL
«	NULL
a	NULL
en	NULL
P	NULL
ig	NULL
b	NULL
'	NULL
bt	NULL
tt	NULL
tnt	NULL
but	NULL
lad	NULL
bot	NULL
ll	NULL
``	NULL
.	NULL

g	NULL
``	NULL
!	NULL

_~-uuu	NULL
ill	NULL
s	NULL
B	NULL
PEER	NULL
E1	NULL
[	NULL
~s	NULL
o	NULL
|	NULL
3	NULL
o	NULL
a	NULL
%	NULL
goax	NULL
E44	NULL
E45	NULL
€	NULL
6	NULL
k	NULL
t	NULL
cg	NULL
t	NULL
1	NULL
&	NULL
~	NULL
2	NULL
1	NULL
1	NULL
t	NULL
ct	NULL
§	NULL
©	NULL
&	NULL
o-	NULL
-	NULL
-	NULL
o=	NULL
<	NULL
b	NULL
fop	NULL
4	NULL
stimulation	NULL
er	NULL
AJ	NULL
Mimi	NULL
~	NULL
FIGURE	NULL
7	NULL
.	NULL

Supershifting	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
E1	NULL
complexes	NULL
by	NULL
anti-.NF-ATp	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
(	NULL
A4	NULL
)	NULL
and	NULL
PEER	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
mock	NULL
treated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
+	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
using	NULL
the	NULL
indicated	NULL
probes	NULL
(	NULL
NF-AT	NULL
,	NULL
E1	NULL
,	NULL
SP-1	NULL
)	NULL
labeled	NULL
with	NULL
°°P	NULL
.	NULL

In	NULL
supershifting	NULL
experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
pre-treated	NULL
with	NULL
nonimmune	NULL
IgG	NULL
,	NULL
anti-.NF-ATp	NULL
,	NULL
anti-NF-ATe	NULL
,	NULL
or	NULL
anti-NF-ATx	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
*P-labeled	NULL
E1	NULL
probe	NULL
.	NULL

These	NULL
Abs	NULL
did	NULL
not	NULL
form	NULL
complexes	NULL
when	NULL
incubated	NULL
with	NULL
the	NULL
probe	NULL
alone	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
Studies	NULL
to	NULL
examine	NULL
factors	NULL
that	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
cyto-kines	NULL
such	NULL
as	NULL
IL-2	NULL
and	NULL
IL-4	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
NF-AT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
activation-inducible	NULL
and	NULL
CsA-sensitive	NULL
gene	NULL
expression	NULL
(	NULL
10	NULL
)	NULL
.	NULL

There	NULL
are	NULL
four	NULL
distinct	NULL
NF-AT	NULL
family	NULL
members	NULL
,	NULL
NF-ATI/NE-ATp	NULL
(	NULL
~120	NULL
pGAD	NULL
[	NULL
_	NULL
]	NULL
plLaczZ	NULL
W	NULL
pmaczenxs	NULL
pGAD-NFATp	NULL
0	NULL
10	NULL
20	NULL
relative	NULL
BGal	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
FIGURE	NULL
8	NULL
.	NULL

Activation	NULL
of	NULL
lacZ	NULL
reporter	NULL
gene	NULL
transcription	NULL
by	NULL
NF-ATp	NULL
in	NULL
yeast	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
was	NULL
generated	NULL
by	NULL
linking	NULL
the	NULL
six	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
E1	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
to	NULL
a	NULL
low	NULL
activity	NULL
promoter	NULL
directing	NULL
expression	NULL
of	NULL
lacZ	NULL
in	NULL
yeast	NULL
.	NULL

The	NULL
control	NULL
(	NULL
pLacZ	NULL
)	NULL
and	NULL
test	NULL
construct	NULL
(	NULL
pLacZ-El	NULL
X	NULL
6	NULL
)	NULL
were	NULL
integrated	NULL
into	NULL
the	NULL
recipient	NULL
yeast	NULL
genomes	NULL
.	NULL

The	NULL
reporter	NULL
yeast	NULL
strains	NULL
were	NULL
then	NULL
transformed	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
expressing	NULL
only	NULL
the	NULL
Gal4	NULL
activation	NULL
domain	NULL
(	NULL
pGAD	NULL
)	NULL
or	NULL
the	NULL
vector	NULL
expressing	NULL
the	NULL
Gal4	NULL
activation	NULL
domain	NULL
fused	NULL
to	NULL
NF-ATp	NULL
(	NULL
pGAD-NF-ATp	NULL
)	NULL
,	NULL
and	NULL
B-gal	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

Representative	NULL
results	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
were	NULL
shown	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3302	NULL
Jurkat	NULL
100	NULL
7	NULL
so	NULL
eo	NULL
3	NULL
2	NULL
=	NULL
60	NULL
4	NULL
2	NULL
4	NULL
80	NULL
q	NULL
©	NULL
E	NULL
k=l	NULL
k	NULL
2	NULL
40	NULL
4	NULL
20	NULL
4	NULL
4	NULL
14	NULL
stimulation	NULL
-	NULL
-	NULL
+	NULL
+	NULL
--	NULL
+	NULL
+	NULL
reporter	NULL
-	NULL
WT	NULL
_	NULL
WT	NULL
_	NULL
Mut	NULL
WT	NULL
_	NULL
WT	NULL
-	NULL
Mut	NULL
expression	NULL
.	NULL

control	NULL
vector	NULL
EXP-NFATp	NULL
vector	NULL
BALL-1	NULL
100	NULL
7	NULL
so	NULL
4	NULL
ke	NULL
9	NULL
3	NULL
@	NULL
60	NULL
4	NULL
€	NULL
1	NULL
5	NULL
3	NULL
®	NULL
0	NULL
1	NULL
3	NULL
)	NULL
3	NULL
2	NULL
40	NULL
7	NULL
20	NULL
7	NULL
j	NULL
1	NULL
{	NULL
2	NULL
sommes	NULL
comm	NULL
.	NULL

com	NULL
stimulation	NULL
~	NULL
+	NULL
+	NULL
-	NULL
+	NULL
+	NULL
reporter	NULL
-	NULL
WT	NULL
_	NULL
WT	NULL
_	NULL
Mut	NULL
WT-	NULL
WT	NULL
-	NULL
Mut	NULL
expression	NULL
-	NULL
control	NULL
vector	NULL
EXP-NFATp	NULL
vector	NULL
FIGURE	NULL
9	NULL
.	NULL

Effect	NULL
of	NULL
transfected	NULL
NF-ATp	NULL
on	NULL
the	NULL
SCM-1a	NULL
promoter	NULL
activity	NULL
.	NULL

Jurkat	NULL
(	NULL
4	NULL
)	NULL
and	NULL
BALL-1	NULL
(	NULL
B	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
CMV-B-gal	NULL
,	NULL
wild-type	NULL
-669/luc	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
or	NULL
-669/luc	NULL
with	NULL
the	NULL
mutated	NULL
E1	NULL
site	NULL
(	NULL
Mut	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
the	NULL
control	NULL
expression	NULL
vector	NULL
or	NULL
the	NULL
expression	NULL
vector	NULL
of	NULL
an	NULL
N-terminally	NULL
truncated	NULL
functional	NULL
NF-ATp	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
mock	NULL
treated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
+	NULL
)	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

After	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
by	NULL
B-gal	NULL
as-say	NULL
,	NULL
the	NULL
luciferase	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
SEM	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
fold	NULL
induction	NULL
from	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
-669/luc	NULL
.	NULL

kDa	NULL
)	NULL
,	NULL
NF-AT2/NF-ATe	NULL
(	NULL
~80	NULL
kDa	NULL
)	NULL
,	NULL
NF-AT3	NULL
(	NULL
~100	NULL
kDa	NULL
)	NULL
,	NULL
and	NULL
NF-AT4/NF-ATx	NULL
(	NULL
~120	NULL
kDa	NULL
)	NULL
(	NULL
12	NULL
,	NULL
20-23	NULL
)	NULL
.	NULL

They	NULL
share	NULL
a	NULL
highly	NULL
homologous	NULL
DNA-binding	NULL
domain	NULL
that	NULL
shows	NULL
a	NULL
weak	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
proteins	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
translocation	NULL
of	NULL
cytoplasmic	NULL
NF-AT	NULL
into	NULL
the	NULL
nucleus	NULL
through	NULL
dephosphorylation	NULL
of	NULL
NF-AT	NULL
by	NULL
Ca*	NULL
*	NULL
/calmodulin-dependent	NULL
phosphatase	NULL
calcineurin	NULL
,	NULL
which	NULL
is	NULL
the	NULL
target	NULL
of	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
CsA	NULL
and	NULL
FK506	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Within	NULL
nuclei	NULL
,	NULL
translocated	NULL
NFE-AT	NULL
and	NULL
a	NULL
de	NULL
novo	NULL
synthesized	NULL
cofactor	NULL
cooperatively	NULL
bind	NULL
to	NULL
a	NULL
composite	NULL
site	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
most	NULL
NF-AT	NULL
binding	NULL
sites	NULL
in	NULL
various	NULL
cytokine	NULL
promoters	NULL
are	NULL
accompanied	NULL
by	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
auxiliary	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
and	NULL
Oct	NULL
(	NULL
10	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
cooperatively	NULL
bind	NULL
to	NULL
multiple	NULL
composite	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
IL-2	NULL
for	NULL
full	NULL
induction	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
distal	NULL
NF-AT	NULL
site	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
also	NULL
consists	NULL
of	NULL
a	NULL
composite	NULL
binding	NULL
site	NULL
for	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
proto-oncogene	NULL
c-maf	NULL
was	NULL
found	NULL
to	NULL
REGULATION	NULL
OF	NULL
SCM-1/LYMPHOTACTIN	NULL
BY	NULL
NF-AT	NULL
be	NULL
expressed	NULL
highly	NULL
selectively	NULL
in	NULL
Th2-type	NULL
T	NULL
cells	NULL
and	NULL
to	NULL
act	NULL
in	NULL
synergy	NULL
with	NULL
NF-AT	NULL
to	NULL
frans-activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
by	NULL
binding	NULL
adjacent	NULL
to	NULL
the	NULL
proximal	NULL
NF-AT	NULL
site	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
designated	NULL
NIP45	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-ATp	NULL
and	NULL
to	NULL
act	NULL
in	NULL
synergy	NULL
with	NULL
NFATp	NULL
and	NULL
c-Maf	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IL-4	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
cell	NULL
type-specific	NULL
cofactors	NULL
assembling	NULL
at	NULL
a	NULL
given	NULL
NF-AT	NULL
site	NULL
determine	NULL
the	NULL
cell	NULL
type-specific	NULL
expression	NULL
of	NULL
various	NULL
cytokines	NULL
.	NULL

SCM-1/lymphotactin/ATAC	NULL
is	NULL
a	NULL
unique	NULL
cytokine	NULL
whose	NULL
expression	NULL
is	NULL
highly	NULL
selective	NULL
for	NULL
activated	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
double-negative	NULL
thymocytes	NULL
,	NULL
intradermal	NULL
y8*	NULL
dendritic	NULL
T	NULL
cells	NULL
,	NULL
intestinal	NULL
intraepithelial	NULL
y8*	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
1-8	NULL
)	NULL
.	NULL

Like	NULL
IL-2	NULL
and	NULL
IL-4	NULL
,	NULL
which	NULL
serve	NULL
as	NULL
models	NULL
to	NULL
examine	NULL
differential	NULL
transcriptional	NULL
regulation	NULL
between	NULL
Th1	NULL
and	NULL
Th2	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
,	NULL
SCM-1	NULL
may	NULL
provide	NULL
a	NULL
unique	NULL
model	NULL
for	NULL
activation-dependent	NULL
gene	NULL
expression	NULL
in	NULL
particular	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
SCM-1	NULL
promoter	NULL
has	NULL
an	NULL
element	NULL
termed	NULL
El	NULL
between	NULL
-108	NULL
and	NULL
-90	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

E1	NULL
is	NULL
essential	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
activation-dependent	NULL
and	NULL
CsA-sensitive	NULL
expression	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
(	NULL
Figs	NULL
.	NULL

2-4	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
E1	NULL
site	NULL
contains	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
(	NULL
TTTCC	NULL
)	NULL
(	NULL
10	NULL
)	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
its	NULL
enhancer	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Unlike	NULL
most	NULL
other	NULL
NFE-AT	NULL
sites	NULL
(	NULL
10	NULL
)	NULL
,	NULL
however	NULL
,	NULL
the	NULL
E1	NULL
site	NULL
probe	NULL
formed	NULL
a	NULL
constitutive	NULL
complex	NULL
,	NULL
termed	NULL
complex	NULL
I	NULL
,	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
SCM-1	NULL
producer	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
even	NULL
from	NULL
SCM-1	NULL
nonproducer	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

With	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
SCM-1	NULL
producer	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
however	NULL
,	NULL
the	NULL
El	NULL
probe	NULL
formed	NULL
a	NULL
higher	NULL
mobility	NULL
complex	NULL
,	NULL
termed	NULL
complex	NULL
II	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
decrease	NULL
in	NULL
complex	NULL
I	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
shift	NULL
from	NULL
complex	NULL
I	NULL
to	NULL
complex	NULL
II	NULL
upon	NULL
cell	NULL
activation	NULL
was	NULL
effectively	NULL
suppressed	NULL
by	NULL
treatment	NULL
with	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
critically	NULL
dependent	NULL
on	NULL
the	NULL
NFE-AT	NULL
core	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
and	NULL
were	NULL
partially	NULL
supershifted	NULL
by	NULL
anti-NF-ATp	NULL
,	NULL
but	NULL
not	NULL
by	NULL
anti-	NULL
NF-ATe	NULL
or	NULL
anti-NF-AT	NULL
'	NULL
x	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NF-ATp	NULL
was	NULL
found	NULL
to	NULL
be	NULL
a	NULL
protein	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
E1	NULL
site	NULL
bait	NULL
in	NULL
the	NULL
yeast	NULL
one-hybrid	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Exogenously	NULL
transfected	NULL
N-terminally	NULL
truncated	NULL
functional	NULL
NF-ATp	NULL
(	NULL
12	NULL
)	NULL
was	NULL
further	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
trans-activating	NULL
the	NULL
SCM-1	NULL
promoter	NULL
in	NULL
the	NULL
El-de-pendent	NULL
manner	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
support	NULL
the	NULL
following	NULL
conclusions	NULL
.	NULL

Transcription	NULL
from	NULL
the	NULL
SCM-1	NULL
promoter	NULL
takes	NULL
place	NULL
through	NULL
a	NULL
shift	NULL
from	NULL
the	NULL
preexisting	NULL
complex	NULL
I	NULL
to	NULL
the	NULL
activation-inducible	NULL
complex	NULL
IL	NULL
The	NULL
NF-AT	NULL
core	NULL
sequence	NULL
(	NULL
TTTCC	NULL
)	NULL
in	NULL
E1	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
complexes	NULL
.	NULL

NF-ATp	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
NF-AT	NULL
core	NULL
sequence	NULL
of	NULL
E1	NULL
.	NULL

NF-ATp	NULL
appears	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
both	NULL
complexes	NULL
,	NULL
but	NULL
induces	NULL
transcription	NULL
of	NULL
the	NULL
SCM-1	NULL
promoter	NULL
only	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

The	NULL
SCM-1	NULL
E1	NULL
site	NULL
thus	NULL
presents	NULL
notable	NULL
differences	NULL
from	NULL
the	NULL
classical	NULL
IL-2	NULL
NFE-AT	NULL
sites	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
IL-2	NULL
NF-AT	NULL
sites	NULL
,	NULL
NF-AT	NULL
proteins	NULL
bind	NULL
only	NULL
after	NULL
stimulation-induced	NULL
nuclear	NULL
translocation	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
E1	NULL
,	NULL
however	NULL
,	NULL
not	NULL
only	NULL
the	NULL
inducible	NULL
complex	NULL
II	NULL
but	NULL
also	NULL
the	NULL
pre-existing	NULL
complex	NULL
I	NULL
seem	NULL
to	NULL
contain	NULL
NF-ATp	NULL
or	NULL
proteins	NULL
immunologically	NULL
reactive	NULL
with	NULL
anti-NF-ATp	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
IL-2	NULL
AP-1	NULL
site	NULL
competitor	NULL
only	NULL
weakly	NULL
inhibited	NULL
the	NULL
activation-inducible	NULL
complex	NULL
II	NULL
of	NULL
E1	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
contrasts	NULL
to	NULL
the	NULL
IL-2	NULL
NF-AT	NULL
sites	NULL
,	NULL
because	NULL
the	NULL
IL-2	NULL
AP-1	NULL
site	NULL
competitor	NULL
effectively	NULL
inhibits	NULL
the	NULL
complex	NULL
between	NULL
the	NULL
IL-2	NULL
NF-AT	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
15	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
no	NULL
potential	NULL
AP-1	NULL
site	NULL
with	NULL
a	NULL
consensus	NULL
sequence	NULL
of	NULL
T	NULL
(	NULL
T/	NULL
G	NULL
)	NULL
ANT	NULL
(	NULL
A/C	NULL
)	NULL
A	NULL
(	NULL
18	NULL
)	NULL
is	NULL
present	NULL
adjacent	NULL
to	NULL
or	NULL
within	NULL
the	NULL
E1	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Like	NULL
SCM-1	NULL
E1	NULL
,	NULL
the	NULL
activation-responsive	NULL
element	NULL
(	NULL
ARE	NULL
)	NULL
located	NULL
between	NULL
-88	NULL
and	NULL
-60	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
was	NULL
bound	NULL
by	NULL
proteins	NULL
from	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
nuclear	NULL
extracts	NULL
of	NULL
EL-4	NULL
T	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
both	NULL
constitutive	NULL
and	NULL
inducible	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
complexes	NULL
of	NULL
the	NULL
IL-4	NULL
ARE	NULL
contained	NULL
proteins	NULL
immunoreactive	NULL
with	NULL
anti-NF-ATp	NULL
and	NULL
anti-NF-ATc	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
SCM-1	NULL
E1	NULL
site	NULL
,	NULL
however	NULL
,	NULL
the	NULL
AP-1	NULL
family	NULL
members	NULL
were	NULL
clearly	NULL
associated	NULL
with	NULL
the	NULL
activation-induced	NULL
complex	NULL
of	NULL
the	NULL
IL-4	NULL
ARE	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
same	NULL
ARE	NULL
was	NULL
also	NULL
critical	NULL
for	NULL
activation-dependent	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
in	NULL
murine	NULL
mast	NULL
cells	NULL
and	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
be	NULL
bound	NULL
by	NULL
nuclear	NULL
proteins	NULL
from	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
mast	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Both	NULL
constitutive	NULL
and	NULL
inducible	NULL
complexes	NULL
contained	NULL
proteins	NULL
immunoreactive	NULL
with	NULL
anti-NF-ATp	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
T	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
the	NULL
AP-1	NULL
family	NULL
members	NULL
were	NULL
not	NULL
associated	NULL
with	NULL
the	NULL
activation-inducible	NULL
complex	NULL
of	NULL
mast	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
of	NULL
mast	NULL
cells	NULL
is	NULL
thus	NULL
rather	NULL
similar	NULL
to	NULL
our	NULL
present	NULL
findings	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
SCM-1	NULL
E1	NULL
site	NULL
,	NULL
however	NULL
,	NULL
the	NULL
constitutive	NULL
complex	NULL
of	NULL
ARE	NULL
formed	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
mast	NULL
cells	NULL
had	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
much	NULL
faster	NULL
than	NULL
the	NULL
activation-induced	NULL
complex	NULL
formed	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
mast	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
some	NULL
NF-AT	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
constitutively	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
certain	NULL
types	NULL
of	NULL
cells	NULL
and	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
elements	NULL
such	NULL
as	NULL
SCM-1	NULL
E1	NULL
or	NULL
IL-4	NULL
ARE	NULL
even	NULL
without	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
about	NULL
41	NULL
kDa	NULL
and	NULL
reactive	NULL
with	NULL
anti-NF-ATp	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
unstimulated	NULL
murine	NULL
mast	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
seen	NULL
whether	NULL
this	NULL
protein	NULL
is	NULL
encoded	NULL
by	NULL
an	NULL
unknown	NULL
gene	NULL
belonging	NULL
to	NULL
the	NULL
NF-AT	NULL
family	NULL
or	NULL
produced	NULL
by	NULL
an	NULL
alternative	NULL
splicing	NULL
or	NULL
a	NULL
post-translational	NULL
modification	NULL
of	NULL
NF-ATp	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
carboxyl-terminal	NULL
end	NULL
of	NULL
NF-AT4/x	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
its	NULL
maximum	NULL
frans-activation	NULL
activity	NULL
,	NULL
and	NULL
notably	NULL
,	NULL
the	NULL
same	NULL
sequence	NULL
is	NULL
well	NULL
conserved	NULL
in	NULL
other	NULL
NF-AT	NULL
family	NULL
proteins	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
multiple	NULL
isoforms	NULL
of	NULL
NF-AT	NULL
proteins	NULL
with	NULL
distinct	NULL
carboxyl-terminal	NULL
regions	NULL
and	NULL
with	NULL
different	NULL
frams-activation	NULL
activities	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
(	NULL
21	NULL
,	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
some	NULL
isoforms	NULL
of	NULL
NF-ATp	NULL
may	NULL
be	NULL
capable	NULL
of	NULL
trans-locating	NULL
into	NULL
the	NULL
nucleus	NULL
without	NULL
cell	NULL
activation	NULL
and	NULL
may	NULL
even	NULL
behave	NULL
as	NULL
a	NULL
negative	NULL
factor	NULL
.	NULL

Upon	NULL
cell	NULL
activation	NULL
,	NULL
they	NULL
may	NULL
be	NULL
replaced	NULL
by	NULL
transcriptionally	NULL
active	NULL
NF-ATp	NULL
translocated	NULL
from	NULL
the	NULL
cytoplasm	NULL
through	NULL
dephosphorylation	NULL
by	NULL
calcineurin	NULL
.	NULL

Transcriptional	NULL
activation	NULL
may	NULL
also	NULL
require	NULL
some	NULL
de	NULL
novo	NULL
synthesized	NULL
cofactors	NULL
specific	NULL
for	NULL
each	NULL
cell	NULL
type	NULL
and	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
NFATp	NULL
.	NULL

The	NULL
El	NULL
element	NULL
of	NULL
the	NULL
SCM-1	NULL
genes	NULL
may	NULL
be	NULL
useful	NULL
to	NULL
explore	NULL
this	NULL
new	NULL
aspect	NULL
of	NULL
transcriptional	NULL
regulation	NULL
by	NULL
the	NULL
NF-AT	NULL
system	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Drs	NULL
.	NULL

Yorio	NULL
Hinuma	NULL
and	NULL
Masakazu	NULL
Hatanaka	NULL
for	NULL
constant	NULL
support	NULL
and	NULL
encouragement	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kelner	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
J.	NULL
Kennedy	NULL
,	NULL
K.	NULL
B.	NULL
Bacon	NULL
,	NULL
S.	NULL
Kleyensteuber	NULL
,	NULL
D.	NULL
A.	NULL
Largacspada	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
J.	NULL
F.	NULL
Bazan	NULL
,	NULL
K.	NULL
W.	NULL
Moore	NULL
,	NULL
T.	NULL
J.	NULL
Schall	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Lymphotactin	NULL
:	NULL
a	NULL
cytokine	NULL
that	NULL
represents	NULL
a	NULL
new	NULL
class	NULL
of	NULL
chemokine	NULL
.	NULL

Science	NULL
266:1395	NULL
.	NULL

2	NULL
.	NULL

Yoshida	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
M.	NULL
Kakizaki	NULL
,	NULL
M.	NULL
Nishimura	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
novel	NULL
C	NULL
or	NULL
y	NULL
type	NULL
chemokine	NULL
,	NULL
SCM-1	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

360:155	NULL
.	NULL

3	NULL
.	NULL

Mueller	NULL
,	NULL
S.	NULL
,	NULL
B.	NULL
Dorner	NULL
,	NULL
U.	NULL
Korthacuer	NULL
,	NULL
H.	NULL
W.	NULL
Mages	NULL
,	NULL
M.	NULL
D	NULL
'	NULL
Apuzzo	NULL
,	NULL
G.	NULL
Senger	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Kroczek	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
of	NULL
ATAC	NULL
,	NULL
an	NULL
activation-induced	NULL
,	NULL
chemokine-	NULL
related	NULL
molecule	NULL
exclusively	NULL
expressed	NULL
in	NULL
CD8	NULL
*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:1744	NULL
.	NULL

4	NULL
.	NULL

Kennedy	NULL
,	NULL
J.	NULL
,	NULL
G.	NULL
S.	NULL
Kelner	NULL
,	NULL
S.	NULL
Kleyensteuber	NULL
,	NULL
T.	NULL
J.	NULL
Schall	NULL
,	NULL
M.	NULL
C.	NULL
Weiss	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
P.	NULL
V.	NULL
Schneider	NULL
,	NULL
B.	NULL
G.	NULL
Cocks	NULL
,	NULL
K.	NULL
B.	NULL
Bacon	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
human	NULL
lymphotactin	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:203	NULL
.	NULL

5	NULL
.	NULL

Bianchi	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Sozzani	NULL
,	NULL
A.	NULL
Zlotnik	NULL
,	NULL
A.	NULL
Mantovani	NULL
,	NULL
and	NULL
P.	NULL
Allavena	NULL
.	NULL

1996	NULL
.	NULL

Migratory	NULL
response	NULL
of	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
to	NULL
lymphotactin	NULL
.	NULL

Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:3238	NULL
.	NULL

6	NULL
.	NULL

Hedrick	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
V.	NULL
Saylor	NULL
,	NULL
D.	NULL
Figueroa	NULL
,	NULL
L.	NULL
Mizoue	NULL
,	NULL
Y.	NULL
Xu	NULL
,	NULL
S.	NULL
Menon	NULL
,	NULL
J.	NULL
Abrams	NULL
,	NULL
T.	NULL
Handel	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1997	NULL
.	NULL

Lymphotactin	NULL
is	NULL
produced	NULL
by	NULL
NK	NULL
cells	NULL
and	NULL
attracts	NULL
both	NULL
NK	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:1533	NULL
.	NULL

7	NULL
.	NULL

Boismenu	NULL
,	NULL
R.	NULL
,	NULL
L.	NULL
Feng	NULL
,	NULL
Y.	NULL
Xia	NULL
,	NULL
J.	NULL
C.	NULL
C.	NULL
Chang	NULL
,	NULL
and	NULL
W.	NULL
L.	NULL
Havran	NULL
.	NULL

1996	NULL
.	NULL

Chemokine	NULL
expression	NULL
by	NULL
intraepithelial	NULL
48	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:985	NULL
.	NULL

8	NULL
.	NULL

Yoshida	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
S.	NULL
Takagi	NULL
,	NULL
M.	NULL
Nishimura	NULL
,	NULL
I.	NULL
Ishikawa	NULL
,	NULL
T.	NULL
Yaoi	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1996	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
two	NULL
highly	NULL
related	NULL
genes	NULL
encoding	NULL
SCM-1/human	NULL
lymphotactin	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

395:82	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

3303	NULL
.	NULL

Yoshida	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
M.	NULL
Kakizaki	NULL
,	NULL
M.	NULL
Nishimura	NULL
,	NULL
S.	NULL
Takagi	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1998	NULL
.	NULL

Identification	NULL
of	NULL
single	NULL
C	NULL
motif-l/lymphotactin	NULL
receptor	NULL
XCR1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:16551	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

NF-ATp	NULL
:	NULL
a	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
co-ordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:274	NULL
.	NULL

Takagi	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
N.	NULL
Fukuhara	NULL
,	NULL
K.	NULL
Fukudome	NULL
,	NULL
M.	NULL
Mincgishi	NULL
,	NULL
S.	NULL
Tsuchiya	NULL
,	NULL
T.	NULL
Konno	NULL
,	NULL
Y.	NULL
Hinuma	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
highly	NULL
specific	NULL
surface	NULL
marker	NULL
of	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
neuroblastoma	NULL
as	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
transmembrane	NULL
4	NULL
superfamily	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
61:706	NULL
.	NULL

McCaifftey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750	NULL
.	NULL

Park	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
K.	NULL
Kaushansky	NULL
,	NULL
and	NULL
L.	NULL
Levitt	NULL
.	NULL

1993	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
interleukin	NULL
3	NULL
(	NULL
IL3	NULL
)	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
:	NULL
role	NULL
of	NULL
AP-1-	NULL
and	NULL
octamer-binding	NULL
proteins	NULL
in	NULL
control	NULL
of	NULL
IL3	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:6299	NULL
.	NULL

Okumura	NULL
,	NULL
K.	NULL
,	NULL
G.	NULL
Sakaguchi	NULL
,	NULL
S.	NULL
Takagi	NULL
,	NULL
K.	NULL
Naito	NULL
,	NULL
T.	NULL
Mimori	NULL
,	NULL
and	NULL
H.	NULL
Igarashi	NULL
.	NULL

1996	NULL
.	NULL

Sp1	NULL
family	NULL
proteins	NULL
recognize	NULL
the	NULL
US	NULL
repressive	NULL
element	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
through	NULL
binding	NULL
to	NULL
the	NULL
CACCC	NULL
core	NULL
motif	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:12944	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Nolan	NULL
,	NULL
K.	NULL
Inaba	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
sites	NULL
on	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:1869	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475	NULL
.	NULL

Wang	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
R.	NULL
Reed	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
olfactory	NULL
neuronal	NULL
transcription	NULL
factor	NULL
Olf-1	NULL
by	NULL
genetic	NULL
selection	NULL
in	NULL
yeast	NULL
.	NULL

Nature	NULL
364:121	NULL
.	NULL

Faisst	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
Meyer	NULL
.	NULL

1992	NULL
.	NULL

Compilation	NULL
of	NULL
vertebrate-encoded	NULL
transcription	NULL
factors	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:3	NULL
.	NULL

Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
A.	NULL
L.	NULL
Maizel	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1993	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
complex	NULL
in	NULL
human	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:14285	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NF-AT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Immunity	NULL
2:461	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATx	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697	NULL
.	NULL

Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFATc	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19898	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
similar	NULL
DNA-binding	NULL
motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
rel	NULL
homology	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4138	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
R.	NULL
Imamura	NULL
,	NULL
S.	NULL
Imai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1997	NULL
.	NULL

Control	NULL
of	NULL
NFATx	NULL
nuclear	NULL
translocation	NULL
by	NULL
a	NULL
calcineurin-regulated	NULL
inhibitory	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:2066	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
Tamura	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
M.	NULL
J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
O'Neill	NULL
.	NULL

1992	NULL
.	NULL

FK-506-	NULL
and	NULL
CsA-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
357:692	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1995	NULL
.	NULL

Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6299	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NFE-AT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2:473	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Hodge	NULL
,	NULL
J.	NULL
W.	NULL
Rooney	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
proto-	NULL
oncogene	NULL
c-maf	NULL
is	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
interleukin-4	NULL
.	NULL

Cell	NULL
85:973	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
H.	NULL
J.	NULL
Chun	NULL
,	NULL
J.	NULL
Rengarajan	NULL
,	NULL
A.	NULL
Alt	NULL
,	NULL
R.	NULL
Licberson	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

NF-AT-driven	NULL
interleukin-4	NULL
transcription	NULL
potentiated	NULL
by	NULL
NIP4S	NULL
.	NULL

Science	NULL
274:1903	NULL
.	NULL

Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
S.	NULL
Sad	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
expanding	NULL
universe	NULL
of	NULL
T-cell	NULL
subsets	NULL
:	NULL
Th1	NULL
,	NULL
Th2	NULL
and	NULL
more	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:138	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

Acquisition	NULL
of	NULL
lymphokine-producing	NULL
phenotype	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:635	NULL
.	NULL

Tara	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
L.	NULL
Weiss	NULL
,	NULL
and	NULL
M.	NULL
A	NULL
.	NULL

Brown	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
activation-responsive	NULL
element	NULL
in	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
is	NULL
the	NULL
site	NULL
of	NULL
an	NULL
inducible	NULL
DNA-protein	NULL
interaction	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:3617	NULL
.	NULL

Tara	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
L.	NULL
Weiss	NULL
,	NULL
and	NULL
M.	NULL
A	NULL
.	NULL

Brown	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
components	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
IL-4	NULL
activation	NULL
responsive	NULL
element	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:4592	NULL
.	NULL

Weiss	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
J.	NULL
Hural	NULL
,	NULL
D.	NULL
Tara	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
Henkel	NULL
,	NULL
and	NULL
M.	NULL
A	NULL
.	NULL

Brown	NULL
.	NULL

1996	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
mast	NULL
cell	NULL
interleukin	NULL
4	NULL
transcription	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:228	NULL
.	NULL

Imamura	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
S.	NULL
Imai	NULL
,	NULL
T.	NULL
Fujino	NULL
,	NULL
T.	NULL
Takano	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1998	NULL
.	NULL

Carboxyl-terminal	NULL
15-amino	NULL
acid	NULL
sequence	NULL
of	NULL
NFATx1	NULL
is	NULL
possibly	NULL
created	NULL
by	NULL
tissue-specific	NULL
splicing	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
transactivation	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3455	NULL
.	NULL

Park	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Takeuchi	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
new	NULL
isoform	NULL
of	NULL
the	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
gene	NULL
family	NULL
member	NULL
NFAT	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:20914	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

